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Abstract
An integrated framework modelling susceptibility to
tuberculosis in homogeneous and admixed populations
Z.Z Gebremariam
Department of Mathematical Sciences,
Mathematics Division,
University of Stellenbosch,
Private Bag X1, Matieland 7602, South Africa.
Thesis: MSc
March 2016
In spite of the wide variety of anti-tuberculosis drugs, tuberculosis (TB),
caused by mycobacterium tuberculosis (MTB), is the second leading infectious
disease after Human Immunodeﬁciency Virus (HIV) or Acquired Immunod-
eﬁciency Syndrome (AIDS), and one of the leading causes of human death
from infectious diseases, especially in Sub-Saharan Africa. Approximately one-
third of the world population are latently infected with MTB, of which, 10 %
progress to active TB. Obstacles in TB control include lengthy treatment reg-
imens of more than 6 months, drug resistance, lack of an eﬀective vaccine
and limited knowledge and incomplete information about factors that trigger
the progression of an MTB infection to disease. Moreover, the association of
TB and HIV or AIDS has also promoted all of the conditions of an explosive
increase in TB incidence and prevalence. Several studies suggest that host
genetic factors also aﬀect susceptibility and resistance to TB. Genome wide
association study (GWAS) provides a way of examining many common vari-
ants in diﬀerent populations to see if any variant is associated with a trait by
searching for small variations, called single nucleotide polymorphisms (SNPs).
However, it is well known that GWAS alone is insuﬃcient to elucidate the
genetic structure of a complex disease and may lead to non conclusive results.
In this thesis, we use a post association analysis, which has been suggested as
a new paradigm to GWAS, to elucidate and analyze human genetic suscepti-
bility in relation to the infecting MTB by combining association signals from
GWAS and available functional and comparative genomics information for hu-
man and MTB. We have identiﬁed 6 disease associated genes for the admixed
ii
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South Africa coloured (SAC) population and 8 disease associated genes for the
homogeneous Ghana-Gambia population. We used a graph-based approach to
establish a relationship between these diﬀerent disease associated genes and
front-line drug targets in relation to MTB. Furthermore, we performed Gene
Ontology (GO) process and pathway enrichment analyses. These yielded sub-
networks, enriched processes and pathways that may play critical role in TB
immunogenicity and pathogenesis. We also investigated ancestry-speciﬁc TB
risk in the SAC population and results revealed that the African Khomani
(Sub-Kalahari San) ancestry highly contributes to disease risk in this pop-
ulation observed to be highly susceptible to TB. Several studies have been
conducted on identifying candidate genes conferring risk susceptibility to TB.
However, most of these studies only analysed relationships between these genes
and the host system. Here, we have also considered the pathogen system, thus
combining host, pathogen and host-pathogen protein-protein functional inter-
actions to examine relationships between host TB susceptibility and patho-
genesis. Furthermore we perform functional relationships between identiﬁed
candidate genes and front-line drug targets based on these functional networks.
This may enhance our understanding about TB susceptibility and pathogene-
sis, and enhance research for TB drug and vaccine development.
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'N geïntegreerde raamwerk modellering vatbaarheid vir
tuberkulose in homogene en vermeng bevolkings
Z.Z Gebremariam
Departement Wiskundige Wetenskappe,
Universiteit van Stellenbosch,
Privaatsak X1, Matieland 7602, Suid Afrika.
Tesis: MSc
Maart 2016
Ten spyte van die wye verskeidenheid van anti-tuberkulose dwelms, tuber-
kulose (TB), wat veroorsaak word deur Mycobacterium tuberculosis (MTB),
is die tweede grootste aansteeklike siektes ná Menslike Immuniteitsgebrekvi-
rus (MIV) of Verworwe Immuniteitsgebreksindroom (VIGS), en een van die
grootste oorsake van menslike dood van aansteeklike siektes, veral in Sub-
Sahara Afrika. Ongeveer een derde van die wêreld se bevolking is sluimerend
besmet is met MTB, waarvan, 10 % vordering aktiewe TB. Struikelblokke in
TB beheer sluit in langbehandelingsregimes van meer as 6 maande, weerstand
teen die medikasie, 'n gebrek aan 'n doeltreﬀende entstof en beperkte kennis
en onvolledige inligting oor faktore wat die verloop van 'n MTB infeksie teen
siektes veroorsaak. Daarbenewens het die vereniging van TB en MIV of vigs
ook bevorder al die voorwaardes van 'n plofbare toename in TB voorkoms en
die voorkoms. Verskeie studies dui daarop dat gasheer genetiese faktore ook
'n invloed vatbaarheid en weerstand teen TB. Genoom wye assosiasie studie
(GWAS) bied 'n manier om die behandeling van baie algemene variante in
verskillende bevolkings om te sien of enige variant is wat verband hou met 'n
eienskap deur te soek vir klein variasies, genoem enkele nukleotied polimorﬁs-
mes (SNPs). Dit is egter bekend dat GWAS alleen onvoldoende is om die ge-
netiese struktuur van 'n komplekse siekte toe te lig en kan lei tot nie afdoende
resultate. In hierdie tesis, gebruik ons 'n post vereniging analise, wat as 'n
nuwe paradigma te GWAS het voorgestel, om toe te lig en te ontleed menslike
genetiese vatbaarheid met betrekking tot die besmet MTB deur die kombina-
sie van assosiasie seine van GWAS en beskikbaar funksionele en vergelykende
genomika inligting vir menslike en MTB. Ons het 6 siekte geassosieer gene
iv
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vir die venmeng Suid-Afrika gekleurde (SAC) bevolking en 8 siekte geassosieer
gene vir die homogene Ghana-Gambië bevolking geïdentiﬁseer. Ons gebruik 'n
graﬁek gebaseerde benadering tot 'n verhouding tussen die verskillende siektes
wat verband hou gene en tussen siekte gene en front-line dwelm teikens te stel
met betrekking tot MTB. Verder het ons uitgevoer Gene Ontologie (GO) pro-
ses en pad verryking ontleed. Hierdie opgelewer sub-netwerke, verryk prosesse
en roetes wat kritieke rol kan speel in die TB immunogenisiteit en patogenese.
Ons ondersoek ook afkoms spesiﬁeke TB risiko in die SAC bevolking en resul-
tate het getoon dat die Afrikaanse Khomani (Sub-Kalahari San) afkoms hoogs
dra by tot siekte risiko in hierdie bevolking waargeneem hoogs vatbaar vir TB
te wees. Verskeie studies is gedoen op die identiﬁsering van kandidaat gene wat
die risiko vatbaarheid vir TB verleen. Maar die meeste van hierdie studies het
net ontleed verhoudings tussen hierdie gene en die gasheer stelsel. Hier het ons
ook gekyk na die patogeen stelsel, dus die kombinasie van gasheer, patogene
en gasheer-patogeen proteïen-proteïen funksionele interaksies om verhoudings
tussen gasheer TB vatbaarheid en patogenese is oorweeg. Verder voer ons
funksionele verwantskappe tussen geïdentiﬁseer kandidaat gene en voorste lyn
dwelm mikpunte gebaseer op hierdie funksionele netwerke. Dit kan ons be-
grip oor TB vatbaarheid en patogenese verbeter, en verbeter navorsing vir TB
dwelm en entstof ontwikkeling.
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Chapter 1
Introduction
Tuberculosis (TB) is an infectious disease caused by a microbial pathogen
called Micobacterium tuberculosis (MTB). TB is one of the leading causes of
human death from infectious diseases (WHO). Since the discovery of TB,
more than 100 years ago, numerous eﬀorts have been made in attempt to
control the disease, including the development of anti-TB vaccine and drugs.
However, in spite of all these eﬀorts TB remains a public health challenge.
According to the World Health Organization (WHO), in 2013 only, 9 million
were infected with TB, and 1.5 million people died from TB.
There is a number of factors making TB control implementation diﬃcult.
The main one rendering even the front line drugs ineﬀective is emergence of
drug resistant TB, which is caused by inconstant adherence to treatment.
For instance, multi-drug resistant TB (MDR-TB) is caused by inappropriate
use of anti-TB drugs, in which case an infected individual does not respond
to standard treatments. The other factor that contributes to TB control
ineﬃciency is the synergy between TB and HIV. TB is still the leading killer
of people living with HIV (WHO).
MTB spreads through air, and anyone exposed to it is at risk. Anyone can
get infected with MTB in diﬀerent ways. There is a number of factors
associated with the exposed individual susceptibility to MTB infection and
pathogenesis, which depends on the immune status of the infected host and
the virulence of the infecting pathogen. A case-control study in West Africa
found out the following host-related and environment-related risk factors
that play a role in the development of tuberculosis: male sex, HIV infection,
smoking, single/widowed/divorced marital status, history of asthma, adult
crowding, family history of TB, and renting the house (Lienhardt et al.,
2005). Though there is a number of host environmental risk factors, many
individuals progress to TB without any identiﬁable risk factors. This
suggests that host genetics variation may inﬂuence susceptibility to disease.
1
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One of following three events occur to an individual who is exposed to MTB:
resists the infection, becomes infected but shows no clinical signs of the disease,
or progresses from mild to severe disease. The occurrence of an outcome
depends on the interaction of environmental factors and the genetic make up of
both host and pathogen. Maliarik and Iannuzzi (2003) has presented evidence
that genetic factors inﬂuence the outcome of exposure to MTB and emphasized
the host genetic make up pointing out the fact that, of those exposed to MTB
in a given similar environment, about 25 percent become infected and from
those only 10 percent develop clinical disease.
1.1 Literature review
1.1.1 Mycobacterium strain variation
Mycobacterium tuberculosis, the pathogen which causes TB, was discovered
in 1882 by Robert Koch, a German physician and bacteriologist (Arisoa,
2012). MTB belongs to the MTB complex which mainly infects human.
Mycobacterium bovis, which predominantly causes tuberculosis in cattle may
also infect human (Cousins et al., 2003). MTB is genetically diverse and this
genetic diversity may lead to signiﬁcant phenotypic diﬀerences between
clinical isolates.
Mutation and recombination lead to DNA sequence variation, which may
result in genetic variants, considered as the outcome of natural selection and
random genetic drift. These evolutionary forces play an important role in
generating bacterial strain variation. This suggests strain variations may be
an indication of selective pressure, which possibly alter genes for adaptation
to the environment during infection and transmission, inﬂuencing
pathogenesis and immunity. Thus, these variations are reﬂected on the
genotype and intracellular lifestyle diﬀerences between diﬀerent strains,
mapping to the strain's virulence and disease phenotype. MTB exhibits very
little genomic sequence diversity compared to other bacteria, and most
genetic variability that has been detected is associated with transposable
elements and drug resistance phenotype (Kubica et al., 1972; Parish and
Brown, 2009). At the whole genomic level, using genomic deletions to type
strains and strain lineages there exists 875 strains and these are classiﬁed in
six main strain lineages (Parish and Brown, 2009).
The global population structure of MTB consists of the six main strain
lineages associated with particular geographic regions (Parish and Brown,
2009): the East-Asian strain lineage is most frequent in East Asia, Russia
and South Africa. The East-Africa-Indian strain lineage mainly occurs on the
Indian subcontinent and in East Africa. The Euro-American strain lineage
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dominates in Europe and the Americans. The West-African strain lineages,
commonly called M.africanum, occur almost exclusively in West Africa, and
the Indo-Oceanic lineage around the Indian Ocean. Most research in the
pathogenesis and imunology of TB has been performed using the laboratory
strains H37Rv (virulent), H37Ra (attenuated), and the clinical strain
CDC1551 and all of these strains belong to the Euro-American strain linage.
The two laboratory MTB strains H37Rv and H37Ra were discovered after
the discovery of the H37 strain in 1905, considered to be the ancestor of
avirulent and virulent colony forms. The (rough) virulent variant form was
designated by H37Rv and the avirulent form by H37Ra (Kubica et al.,
1972). H37 strain and the clinical strain CDC1551 are derived from common
parental strain as shown in Figure 1.1 (Mazandu, 2010). In this work, we use
the clinical strain CDC1551 to analyse TB disease outcome.
Strain CDC1551 or "Oshkosh" was isolated in an outbreak that occured in a
rural community on the border of Tennessee Kentucky during the mid-1990s
from a 21-year old male clothing factory worker in US (Parish and Brown,
2009; Arisoa, 2012). The CDC1551 strain is highly infectious compared to
the virulent strain H37Rv and has more immunoreactivity than H37Rv and
other clinical strains (Fleischmann et al., 2002).
Figure 1.1: Schematic diagram depicting evolution of three MTB strains,
H37Ra, H37Rv and CDC1551 (Mazandu, 2010)
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1.1.2 Genetics and TB susceptibility
Most of the information about the human body is contained in the genetic
matter called chromosome. The chromosome contains tightly coiled strands
of DNA, a molecule that encodes the genetic instructions used in the
development and functioning of the body. These genetic instruction codes
play a major role to the host susceptibility to or outcome of a disease. As a
result of the advancement in high-throughout biology technologies, it is now
possible to study the whole genome of individuals with and without TB,
allowing scientists to identify small genetic regions, which may cause
increased TB susceptibility or resistance.
MTB infection occurs in every part of the world. One third of the world
population has TB, but only ten percent of those who get infected with MTB
will develop clinically active disease. This indicates that TB pathogenesis
diﬀers considerably between individuals, leaving a high percentage of
individuals infected (≈ 90%) with MTB worldwide non-infectious. This
suggests that host susceptibility is an important risk factor with a strong
genetic factor determining the outcome of infection. Bellamy (1998) shows
that there are more reasons for the development of the disease beyond
environmental factors and the pathogen virulence. It has been shown also
that, though it is diﬃcult to identify all tuberculosis susceptibility genes,
there is convincing evidence that host genetic factors are important in
determining the outcome of infection.
In relation to the linkage between TB and host genetics (Maliarik and
Iannuzzi, 2003) black populations have higher rates of tuberculosis and are
also more likely to develop the more fulminate forms of the disease.
Geographically South Africa has the highest occurrence of TB and Western
Europe the lowest (Maliarik and Iannuzzi, 2003). Although these racial
diﬀerences and incidence variation may result from environmental and
socioeconomic factors, there is evidence that the diﬀerence is strongly
inﬂuenced by genetic factors.
Stead et al. (1990) found that, among over 25 000 tuberculin negative nursing
home residents, black subjects were twice as likely to become infected with
tuberculosis as white subjects living in the same environment (Bellamy,
1998). The other evidence that shows that genetics factors are important in
tuberculosis susceptibility is the twin studies (Schurr, 2011). It has been
found that there is a much higher concordance for diseases among
homozygous twins than dizygous twins. This suggests that even within
ethnic groups, host genetic factors exert a major inﬂuence on tuberculosis
susceptibility.
Stellenbosch University  https://scholar.sun.ac.za
CHAPTER 1. INTRODUCTION 5
Admixed mapping, the process of ﬁnding areas of the genome that harbour
genetic variants that increase risk of developing a disease, has been used to
discover disease susceptibility genes. Due to the existence of population
admixture, this process is highly dependent on accuracy of a local ancestry
inference (LAI) per individual across their genome (Daya et al., 2014a).
When admixture happens between two or more previously isolated
population groups, recombination occurs and results in chromosomes that are
a chunk of ancestry blocks derived from diﬀerent source populations. Local
ancestry inference (LAI) is used to determine the bounds of these segments
and to assign the most probable source ancestries to them. This can be done
using statistical techniques given the genetic data of an admixed individual
and their source population.
The South African coloured (SAC) population is an example of an admixed
population with a mixed ancestry whose genomes consist of ﬁve diﬀerent pop-
ulation. These ﬁve populations are Yoruba in Ibadan (YRI : 33 %), Khomani
SAN (KHS : 31 %), Caucasian Western European (CEU : 16 %), Gujarati
Indian (GIH : 13 %), and Southern Han Chinese (CHE : 7 %) (Chimusa et al.,
2013). SAC population has a high incidence of TB and is ideally suited to
the discovery of TB susceptibility genetic variants and their probable ethnic
origins. Daya et al. (2014a), in their study on the admixed SAC population,
have shown that African ancestry is associated with higher risk of TB infection,
whereas European and Asian ancestries are protective.
1.1.3 Pharmacogenetics and anti-TB drugs
After the discovery of TB, signiﬁcant eﬀorts have been made in drug
discovery and administration against TB. The ﬁrst antibiotic agent for
treating TB, streptomycin was discovered in 1943. Subsequently, due to the
appearance of an MTB drug resistance strain, other drugs were added. The
cure rate increased and antibiotic resistance decreased when the two
antituberclosis agents, thiacetazone and paraaminosalicylic were introduced
and either of them were given in combination with streptomycin. In 1951
isoniazid was introduced for worldwide use, then pyrazinamide (1952),
cycloserine (1952), ethionamide (1956), rifampin (1957), and ethambutol
(1962) followed (Keshavjee and Farmer, 2012).
Though new clinically improved drugs were developed, (Maliarik and
Iannuzzi, 2003) every new drug led to the selection of mutations conferring
resistance to it and using a single drug led to drug resistance. This has
resulted in the introduction of multi-drug treatment. Through a series of
multicountry clinical trials, led by the British Medical Research Council, a
four-drug regimen was recommended for use in patients with newly
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diagnosed tuberculosis (Keshavjee and Farmer, 2012). The four core ﬁrst-line
drugs which are particularly used to treat an active TB patient who has not
taken any TB drug treatment are isoniazid, rifampicin, pyrazinamide, and
ethambutol.
Currently, these four drugs called ﬁrst- or front-line drugs are used to treat
TB through Direct Observed Treatment (DOT), a control strategy
implemented by the World Health Organization (WHO) in order to
control TB globally. Moreover, there is a vaccine, called Bacille
Calmette-Guerin or BCG, used to prevent TB. This vaccine is generally
given to infants and children, but in some cases it is only recommended for
individuals with speciﬁc criteria and in agreement with a TB expert
(http://www.cdc.gov/tb/topic/vaccines/).
A drug taken has diﬀerent responses due to diﬀerent factors, such as
environmental factors and genetic diﬀerences. It is likely that individuals
who are subjected to the same drug respond diﬀerently. This inter-individual
drug response variability is one of the challenges in drug development.
Generally, drug response can be classiﬁed using two criteria: eﬃcacy and
toxicity. These interindividual drug response diﬀerences are higher among
individuals belonging to the same population than within an individual at
diﬀerent times (Ramachandran and Swaminathan, 2012).
Single Nucleotide Polymorphisms (SNPs), the most common genetic
variations among people, are key in determining individual's disease
susceptibility and drug response. SNPs can occur anywhere along the
genome and most SNPs occurring in non-coding or non-regulatory regions of
the genome are functionally silent and has no eﬀect. But some SNPs that are
found in coding regions may alter protein or gene product structure, leading
to disease susceptibility or variation in drug response. The altered genes or
proteins that are responsible for drug response are called pharmacogenes.
Pharmacogenetics studies to identify variation in drug response have provided
ample examples of causal relations between genotypes and drug response to
account for phenotype variations of clinical importance in drug therapy. Phar-
macogenetics studies how genetics aﬀects drug response and it revolutionized
drug development to personal level based on genetic make up (Alwi, 2005).
1.1.4 Protein-protein interactions
There are 100 trillion cells in the human body and inside each human cell
nucleus there are 23 pairs of chromosomes that come from each parent
(http://www.thehumangenome.co.uk/THE_HUMAN_GENOME/Primer.html).
Each chromosome is made up of two coiled double helix shaped strands of
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deoxyribonuclic acid (DNA). These two strands of DNA are composed of a
sequence of four bases called nucleotides: adenine (A), guanine (G), cytosine
(C), and thymine (T), and the human genome contains approximately 3
billion nucleotides. A gene is a locus or region of DNA that contains code for
making proteins which are the building blocks of life.
The human genome project started in 1984 and completed in 2003 has
produced the whole human genome (http://www.genome.gov/). The
microbial genome sequencing projects yielded complete genome sequence of
crucial microbial pathogens of humans, animals and plants (Mazandu and
Mulder, 2011a). The complete genome of the MTB clinical strain
(CDC1551) have been sequenced (Kinsella et al., 2003). As a result of the
availability of complete genome sequences of diﬀerent organisms, the complex
properties of living organisms can be studied at the system level. These
systems are made up of molecules, which interact among themselves to yield
the complex properties of living things.
Proteins or gene products are responsible for most of biological functions in a
body. Very often proteins do not work in isolation, they interact directly or
indirectly with each other in diﬀerent processes and pathways to perform
their functions. Hence, studying protein-protein interactions (PPIs) is
important to understand how proteins function at the systems level. This
can help identify pathways and elucidate proteins that play a major role in
disease outcome, pathogenesis and drug response.
Protein interactions include physical and functional interactions (Yellaboina
et al., 2007). Physical interactions are interactions that involve physical
contact between proteins. On the other hand, functional interactions do not
necessarily involve direct physical contact, but it refers to the mechanism
through which a protein participates in cell functions (Mazandu and Mulder,
2011a).
Generally, protein-protein interactions can be detected experimentally or by
computational analysis. Functional interactions, can be retrieved from
biological knowledge such as coexpression data from microarray analysis.
Physical interactions, on the other hand, can be detected using direct
experimental techniques, such as pull-down assays, co-immunoprecipitation,
or tandem aﬃnity puriﬁcation coupled to mass spectrometry (Yellaboina
et al., 2007).
Protein interactions can be modelled as a network, referred to as a protein-
protein functional network or interactoms. The network structure can be repre-
sented using mathematical objects called graphs consisting of nodes or vertices
and edges (Wagner, 2003). In a protein interaction, graph or network nodes
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or vertices are proteins and edges or links represent pairwise interactions or
functional relationships within an organism. In this work, integrated protein-
protein interaction (PPI) networks are built using PPIs from diﬀerent data
sources. We used functional protein-protein interactions for human and MTB,
and human-MTB interaction network.
1.2 Thesis rationale and objectives
Populations of diﬀerent ancestry may diﬀer in disease susceptibility and drug
response. Host and pathogen genetics play a major role in the susceptibility
or outcome of the disease in the host. As pointed out previously, some
studies have shown that black populations are more susceptible (?) and in
South Africa the admixed South African Coloured (SAC) population residing
in the Western Cape have a high incidence of TB (Chimusa et al., 2014). In
addition, it has also been found that there is a positive correlation between
African San ancestry and TB susceptibility, and negative correlations with
European and Asian ancestries (Daya et al., 2014b; Chimusa et al., 2014).
Host susceptibility is an important risk factor to the progression from MTB
infection to active disease, but factors that govern this progression are not
well understood. We aim at developing a model for analysing human genetic
susceptibility in relation to the MTB system and identify genes, biological
processes, and potential pathways involved in TB susceptibility. We check
whether there is correlation between genome-wide association studies
(GWAS) candidate genes and previously identiﬁed drug targets by combining
association signals from GWAS and available functional and comparative
genomic information for humans and MTB. In addition, we predict
interactions between humans and the bacterial pathogen inﬂuencing TB
outcome. This contributes to advancing research for TB drug and vaccine
design, and thus might ultimately improve disease diagnosis and prevention.
A graph-based model is developed using protein-protein functional interac-
tion of the organisms. We analyse human genetic susceptibility in relation
to the infecting mycobacterium tuberculosis (MTB) system. The correlation
between GWAS candidate genes and previously identiﬁed drug targets are
analysed at system level using protein-protein interaction. The main objective
of this research is to elucidate the relationship between human and pathogen
in TB disease outcome in association with front-line drug targets at the system
level. In this work, high-throughput biological data of the MTB clinical strain
(CDC1551) and human genetic data of an admixed South African Coloured
(SAC) population and the homogeneous Ghana-Gambia population are used.
In summary this project proposes a systems level based model to:
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1 Discover possible novel risk genes by combining moderate GWAS signals
and relationship between theses genes in association with front-line drug
targets;
2 Identify enriched biological processes and pathways in which these risk
genes are involved;
3 Discover ethnic diﬀerences in disease risk and investigate
ancestry-speciﬁc disease in the context of the SAC population;
4 Determine human-pathogen interactions inﬂuencing diﬀerent phenotypes
or infection outcomes.
1.3 Project outline
The rest of this thesis is organized as follows: In chapter two, we describe diﬀer-
ent databases used to retrieve the dataset used in this study and discuss scor-
ing schemes of protein-protein functional interactions from each data source.
Chapter three provides the details on the integrated scoring scheme used to
produce uniﬁed networks integrating interactions from diﬀerent databases. We
also discuss about topological properties of networks and network centrality
measures which numerically characterize the importance of proteins in and
general features of the network. Moreover, we describe clustering method
to identify sub-graphs, approaches used to elucidate signiﬁcant processes and
pathways implicated in the disease and for combining eﬀects of diﬀerent SNPs
and ancestry contribution at gene level. Chapter four presents and discusses
results obtained by applying diﬀerent methods. We conclude this thesis in
chapter ﬁve, summarizing diﬀerent results obtained and potential future work.
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Chapter 2
Exploring diﬀerent sources of
datasets used
There has been an exponential increase in biological data for several model
organisms, including human, animals, plants and their crucial microbial
pathogens, as results of high-throughput biology technologies and
bioinformatics scanning approaches. The use of computational methods and
algorithms have enabled the extraction of information concerning complex
organization and relatedness of these genomes, including gene content and
relationships between these genes, as well as their sizes and other essential
features. These biological datasets are stored in public repositories and often
freely available to the research community. These include the international
Haplotype Map (HapMap) Phase 3 at http://www.hapmap.org, the 1,000
Genomes Project (http://www.1000genomes.org/), the Universal Protein
(UniProt) and the European Bioinformatics Institutes (EBI) resources
(http://www.ebi.ac.uk/). In this thesis, we use a systems level analyses
integrating genotype data, protein-protein interactions, other functional,
genomics and pharmaceutical data into a uniﬁed framework to identify
disease-related genes and enriched processes and pathways in which they are
involved.
2.1 Retrieving GWAS and protein target
datasets
Genome-wide association study (GWAS) (Jia et al., 2011) examines many
common variants in diﬀerent populations to check whether any variant
(genotype) is associated with a trait (phenotype) by searching for small
variations, called single nucleotide polymorphisms (SNPs), also referred to as
variants or alleles. There have been many successful GWAS (Welter et al.,
2014), but detecting variants that have low disease risk is still a challenge.
10
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This is mostly due to the fact that GWAS is a single-marker testing
model (Chimusa et al., 2015), which may fail to identify genetic variants with
low or moderate risk, which could not meet the standard genome-wide
signiﬁcance threshold of 5.00e-08, thus yielding an increased number of false
negatives. In the context of complex diseases, such as TB, where multiple
genetic and the environmental factors contribute to the disease outcome
through gene-gene and gene-environment interactions (Zhang et al., 2014), it
is essential to combine the eﬀects of all SNPs within genes in order to
increase the likelihood of identifying disease genes showing weak genetic
eﬀects or having strong epistatic eﬀects.
For this study, genetic data are extracted from diﬀerent literature sources.
The genetic data includes the set of human SNPs with their p-values and
corresponding genes. SNPs associated with TB, p-values and ancestry
contribution for the South African Coloured (SAC) population are taken
from Chimusa et al. (2014). TB associated SNPs for the homogeneous
Ghana-Gambia population are retrieved from Thye et al. (2010). We use a
post-GWAS meta-analysis techniques to combine the eﬀect of diﬀerent SNPs
within a gene under consideration in order to prioritize essential
genes (Crombie and Davies, 2009; Begum et al., 2012).
Moreover, we investigate how front-line drug targets and disease associated
genes interact in the system. Human target proteins or enzymes metabolizing
TB front-line drugs are collected from the drug bank database (http://www.
drugbank.ca/drugs) and one common target protein (P11473) is added from
the Guide to Pharmacology database at http://www.guidetopharmacology.
org/.
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Table 2.1: TB ﬁrst line drugs and their target proteins
Target Gene name Description Drug
P11712 CYP2C9 Cytochrome P450 2C9 Rifampin, Isoniazid
P05177 CYP1A2 Cytochrome P450 1A2 Rifampin, Isoniazid, Pyrazinamide
P10632 CYP2C8 Cytochrome P450 2C8 Rifampin, Isoniazid
P08684 CYP3A4 Cytochrome P450 3A4 Rifampin, Isoniazid, Pyrazinamide
P20813 CYP2B6 Cytochrome P450 2B6 Rifampin
P22309 CYP2B6 Cytochrome P450 2B6 Rifampin
P33261 CYP2C19 Cytochrome P450 2C19 Rifampin
P11509 CYP2A6 Cytochrome P450 2A6 Rifampin , Isoniazid
P05181 CYP2E1 Cytochrome P450 2E1 Rifampin , Isoniazid
Q9HB55 CYP3A43 Cytochrome P450 3A43 Rifampin
P20815 CYP3A5 Cytochrome P450 3A5 Rifampin
P24462 CYP3A7 Cytochrome P450 3A7 Rifampin
Q02928 CYP4A11 Cytochrome P450 4A11 Rifampin
O75469 NR1I2 Nuclear receptor subfamily 1
group I member 2
Rifampin
P11473 VDR Vitamin D3 receptor Rifampin, Isoniazid, Pyrazi-
namide, Ethambutol
P10635 CYP2D6 Cytochrome P450 2D6 Isoniazid
P11245 NAT2 Arylamine N-acetyltransferase 2 Isoniazid
P47989 XDH Xanthine dehydrogenase/oxidase Pyrazinamide
Q06278 AOX1 Aldehyde oxidase Pyrazinamide
2.2 Identiﬁcation of protein-protein functional
interactions
In order to produce the protein-protein functional network, data are collected
from diﬀerent databases. In addition to the PPI data directly downloaded
from diﬀerent freely available online databases, protein-protein functional
interactions are also predicted from protein sequence similarity and
conserved protein signature matches.
The protein-protein interaction datasets are downloaded from STRING,
BioGRID, DIP and IntAct databases. Additional protein functional
interactions are predicted using protein sequence similarity and conserved
protein signature matches (shared domain) data derived from UniProt and
InterPro databases, respectively (Table 2.2). Unless speciﬁed explicitly,
throughout this thesis sequence data refers to sequence similarity and shared
domain data.
STRING (Search Tool for the Retrieval of Interacting Genes/Proteins) is a
freely accessible online database of known and predicted protein interactions
(Szklarczyk et al., 2015). Its data is derived from experiments, public
literature collections, and computational prediction methods based on
domain fusion, gene fusion, gene neighbourhood, homology and phylogenetic
proﬁling. It provides full coverage and accesses to experiential and predicted
interactions between proteins in more than 1000 organisms.
BioGRID (Biological General Repository for Interaction Datasets) is a freely
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accessible database of physical and genetic interactions. Interactions stored
in this database are compiled through comprehensive curation eﬀorts. The
current version (3.4.129) holds over 830,000 interactions curated from both
high-throughput datasets and individual focused studies, as derived from over
55,000 publications in the primary literature (http://www.thebiogrid.org).
DIP (Database of Interacting Proteins) stores experimentally determined
protein interactions. It combines information from a variety of sources to
generate a single, consistent set of protein-protein interactions. The data
stored within the DIP database were curated, both, manually by expert
curators and also automatically using computational approaches that utilize
the knowledge about the protein-protein interaction networks extracted
from the most reliable, core subset of the DIP data. Currently the
database contains 27883 proteins, 749 organisms, and 79646 interactions
(http://dip.doe-mbi.ucla.edu).
IntAct is a freely available online database that contains molecular
interaction data derived from literature curation or direct data depositions
by expert curators. It also contains valuable tools that can be used to search
for, analyze and graphically display protein interaction data from a wide
variety of species. IntAct currently contains 82491 proteins, 351399
interactions of diﬀerent species of which 39.1% is for human, these data get
updated whenever a new molecular interaction has been submitted
(http://www.ebi.ac.uk/intact).
InterPro is a public data resource for protein families, domains or protein
signatures and functional sites (http://www.ebi.ac.uk/interpro).
InterPro provides functional analysis of protein sequences by classifying them
in to families and predicting domains and important sites. InterPro
integrates signatures from diﬀerent databases in to a single searchable
resource and uses these signatures to classify proteins.
UniProt (Universal Protein Resource) is a freely accessible database for pro-
tein sequence data and functional annotation data of proteins (http://www.
uniprot.org). It is composed of four components; the UniProt Knowledge-
base (UniProtKB), the UniProt Reference Clusters (UniRef), the UniProt
Archive (UniParc), and the UniProt Metagenomic and Environmental Se-
quences (UniMES) databases.
Stellenbosch University  https://scholar.sun.ac.za
CHAPTER 2. EXPLORING DIFFERENT SOURCES OF DATASETS USED 14
Table 2.2: Data source databases
Database Description Data type Reference
STRING Search Tool for the Retrieval of
Interacting Genes/Proteins
Pretreated protein interaction http://string-db.org
BioGRID Biological General Repository
for Interaction Database
Physical and genetic interactions http://www.thebiogrid.org
DIP Database of Interacting Proteins Protein interactions http://dip.doe-mbi.ucla.edu
IntAct Molecular Interactions Experimentally determined pro-
tein interactions
http://www.ebi.ac.uk/intact
UniProt Universal Protein Resource Protein sequence data http://www.uniprot.org
InterPro Integrated documentation re-
sources for protein families, do-
mains and functional sites
Protein signature or shared do-
main
http://www.ebi.ac.uk/interpro
Drug Bank A unique bioinformatics and
cheminformatics resource that
combines detailed drug data
with comprehensive drug target
Drugs and drug targets http://www.drugbank.ca/drugs
GOA Gene Ontology annotation Protein annotations http://geneontology.org/
IUPHAR/BPS Guide to PHARMACOLOGY Drugs and Drug targets http://www.
guidetopharmacology.org/
KEGG Kyoto Encyclopedia of Genes
and Genomes
Genomes, biological pathways,
diseases, drugs
http://www.kegg.jp/
2.3 Scoring protein-protein functional
interactions
As pointed out previously, functional interactions are retrieved from multi-
ple sources, including the STRING database (Szklarczyk et al., 2015) and
protein-protein interaction datasets described in Table 2.2. We mapped dif-
ferent protein identiﬁers from diﬀerent sources to UniProt accession numbers
for human (homo sapiens) and MTB strain CDC1551 downloaded from the
UniProt database (UniProt Consortium, 2015). Each dataset source produces
its protein-protein functional network conﬁguration of its own, which raises the
issue of accuracy of each network conﬁguration, especially as these interactions
are retrieved from inaccurate and noisy data produced by high-throughput
biology experiments. This issue is alleviated by assigning a conﬁdence or re-
liability score to each functional interaction, which represents the likelihood
of the occurrence of the interaction under consideration and quantiﬁes our
conﬁdence level in this functional interaction.
2.3.1 Scoring interactions from sequence data
For this we downloaded protein sequence data for human (reviewed) and My-
cobacterium tuberculosis clinical strain CDC1551 from the UniProt database
using their taxonomy numbers 9606 and 83331, respectively. A FASTA (canon-
ical) ﬁle, this is the ﬁle containing protein sequences for the organism or strain
under consideration is downloaded. For each organism, we also downloaded a
tab-separated ﬁle, which is a protein reference ﬁle for the organism or strain
under consideration. Similarly, protein signature or shared domain data is
downloaded from the InterPro database.
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2.3.1.1 Computing sequence similarity based conﬁdence score
Basic Local Alignment Search Tool (Altschul et al., 1990, 1997), referred to
as BLAST, is used to retrieve sequence similarity data used to derive
protein-protein functional interactions. BLAST is an algorithm for sequence
similarity searching and sequence comparison. It aligns two sequences and
outputs alignments which produce high alignment bit score and calculates
the statistical signiﬁcance of matches. The availability of genome sequences
has enabled analyses of genes and their products within an organism and
their comparisons across diﬀerent organisms through the identiﬁcation of
similarity between sequences. Protein-protein functional interactions are
predicted from these sequence similarity scores by assuming that two protein
sequences which are signiﬁcantly similar are evolutionary linked and might
thus share similar functions at the molecular levels or participate to the same
biological process or act in the same pathway without direct physical contact.
Using protein sequence data, a local Blast database for each organism is created
and each organism proteome is Blasted against itself. The Blast result for each
organism is cleaned, and a ﬁle containing only protein pairs and Blast scores
is produced. The link reliability or conﬁdence score of a protein pair (p, q),
Sseq (p, q), is calculated using alignment bit scores produced from BLAST as
suggested in (Mazandu and Mulder, 2011b) and given by:
Sseq (p, q) = A (p, q)
2×max{S (p, p) , S (q, q)} (2.3.1)
where A (p, q) = S (p, q) + S (q, p) is the bit score obtained by aligning the
protein sequence q against the protein sequence p and p against q and quanti-
ﬁes their conserved biological features during evolution (Bastien et al., 2005;
Bastien and Maréchal, 2008) with S (p, q) the BLAST bit score resulting from
aligning the protein sequence q against protein sequence p. This bit score
A (p, q) reﬂects the amount of information shared by these two protein se-
quences due to their common origin and parallel evolution under similar se-
lective pressure. This shared information is normalized by dividing it with
the maximum possible relative entropy produced by aligning these protein se-
quences, which is 2×max{S (p, p) , S (q, q)}, in order to correct the bias which
may be yielded by an unpredictable increase of bit score. Thus, formula (2.3.1)
produced normalized conﬁdence score (value range between 0 and 1) which
only depends on the two protein sequences under consideration and measures
how the protein sequence `p' is able to predict the protein sequence `q' and
vice versa, and includes the case where no similarity is identiﬁed between two
protein sequences, producing the conﬁdence score of 0.
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2.3.1.2 Computing shared domain-based conﬁdence score
The InterPro signature data downloaded from the InterPro database is pro-
cessed with the protein reference ﬁle, the tab separated ﬁle, and we produced
a ﬁle that contains proteins with their InterPro signature for each organism.
Finally, we computed the conﬁdence or reliability score, Sdom (p, q), between
pairwise proteins p and q, using an information-theory based model suggested
in (Mazandu and Mulder, 2011b), as follows:
Sdom (p, q) = 1−H2 (h) /bit (2.3.2)
with H2 (h) the binary entropy function quantifying the uncertainty associated
with the number s of common InterPro signatures hits, given by
H2 (h) = −h log2 (h)− (1− h) log2 (1− h) (2.3.3)
where the conﬁdence level function h ≡ h (s, σ, β) is given by
h (s, σ, β) = φ
(
sβ
σ
)
(2.3.4)
with φ the cumulative probability distribution of the standard normal distri-
bution deﬁned as follows:
φ (x) =
1√
2pi
ˆ x
−∞
exp
(
−z
2
2
)
dz (2.3.5)
σ the standard deviation and β ≥ 0.5 the calibration control parameter, re-
ﬂecting the impact of the conﬁdence level for the InterPro signature dataset.
2.3.2 Scoring interactions from other datasets
Other human and MTB protein-protein functional interactions are mainly ex-
tracted from the STRING database (Szklarczyk et al., 2015) using the organ-
ism taxonomy number, accessed on 25 October, 2015. This database con-
tains predicted and known protein-protein interactions derived from genomic
context, text mining, information from pathway databases and biological ex-
periments. These protein-protein functional interactions are used with their
conﬁdence or reliability scores as deﬁned by the STRING system. For the
human functional network, more protein functional interaction data are also
derived from the Biological General Repository for Interaction Datasets (Bi-
oGRID) (Chatr-Aryamontri et al., 2013), expert-curated and experimentally
determined PPI from the Database of Interacting Proteins (DIP) (Salwinski
et al., 2004) and the IntAct database. These interactions are assumed to be
of reasonable quality and a ﬁxed conﬁdence score of 0.85 is assigned to each
predicted interactions.
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2.3.3 Scoring human-MTB protein-protein functional
interactions
Human-MTB protein-protein functional interactions are derived from manual
curation of the literature and predicted using the interologs model based on
human and MTB functional networks. Interologs are conserved interactions
between a pair of proteins which have interacting orthologs in another organ-
ism. The interaction between proteins X and Y in one species is referred
to as interologs of the interaction X ′ and Y ′ in another species if X ′ and
Y ′ are orthologs (have common ancestor) of X and Y respectively (Arisoa,
2012). In order to infer these interologs, interaction datasets are collected
from manually veriﬁed interactions between human and bacterial proteins
from the Host-Pathogen Interaction database (HPIDB) (Kumar and Nanduri,
2010) and the Pathosystems Resource Integration Center (PATRIC) (Sny-
der et al., 2007), and intra-species interacting pairwise proteins from DIP,
MINT and IntAct. Protein orthologs were retrieved Ensembl BioMart at
http://www.ensembl.org/biomart/ and interologs predicted based on the
premise that orthologs of interacting proteins also interact. These interactions
are assigned a score of 0.60 as they are assumed to be of high quality. Note that
these functional interactions are complemented by functional interactions from
sequence data, more speciﬁcally interactions predicted from protein sequence
similarity and shared domains between proteins from the InterPro database.
2.4 Gene Ontology annotation and pathway
datasets
Cells are functional units of life and each protein or gene product in a cell
contributes to diﬀerent biological functions by collaborating in pathways and
processes, and interacting with the cellular environment in order to promote
the cell's growth and function (Mazandu and Mulder, 2011a; Mulder et al.,
2014). Generally, proteins have six primary functions in our body; repair and
maintenance, energy production, hormone creation, chemical reaction
enzymes, and transportation and storage of molecules. Thus, performing
functional analyses of protein sets is useful to understand the biological
phenomena underlying a given protein set by identifying enriched processes
and pathways in which these proteins are involved. In case where these
proteins or genes are implicated in the disease outcome, this analysis may
enable the identiﬁcation of essential processes and pathways involved in the
disease. Understanding these processes and pathways can contribute to the
development of eﬀective therapy which considers underlying causes of disease
and minimizes side eﬀects. Biological process and pathway information are
found in bioinformatics resources, such as the Gene Ontology (GO) and Gene
Ontology Annotation (GOA) (Huntley et al., 2015), and the Kyoto
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Encyclopedia of Genes and Genomes (Kanehisa and Goto, 2000), referred to
as KEGG, databases.
GO is designed as a directed acyclic graph (DAG) in which each node is a
biological term describing genes and proteins in any organism, and
produces a well adapted platform to computationally process data at
the functional level (Mazandu and Mulder, 2013a). GO has been
widely adopted and successfully deployed in several biological and
biomedical applications, ranging from theoretical to experimental and
computational biology (Mazandu and Mulder, 2013b). Currently, more
than 4.2 × 107 proteins (see GOA UniProt version 152 at
http://www.ebi.ac.uk/GOA/uniprot_release, released on 13 February,
2016) are already annotated with GO terms and this dataset is integrated
into the GOA database under the GOA-UniProt project (Huntley et al.,
2015), mapping diﬀerent annotated proteins from UniProt knowledge-base
(UniProtKB) to their GO annotations. It has been suggested that
incorporating the GO structure in GO annotation-based protein analyses has
signiﬁcantly contributed to the improved outcomes of protein functional
analyses (Mazandu and Mulder, 2013b,a). Thus, several GO semantic
similarity measures (Mazandu and Mulder, 2013b; Mazandu et al., 2015) have
been proposed in recent years and have enabled the integration of biological
knowledge embedded in the GO structure into diﬀerent biological analyses.
In this study, we use the GO biological process data based semantic similar-
ity model built on the GO-universal metric (Mazandu and Mulder, 2012a) to
identify enriched biological processes for a given set of proteins. The complete
set of GO data and protein-GO term associations are downloaded from the GO
and GOA (version 148, released on 11 November, 2015) databases, accessed
on the 16th November, 2015. Finally, for pathway enrichment analyses, litera-
ture was mined and pathway dataset was extracted from KEGG. The Protein
Interaction Network Viewer tool (PINV) is used to visualize interactions of
interest.
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Chapter 3
Integrative model for analyzing
susceptibility to tuberculosis
As pointed out previously, GWAS as a single marker-based model is very
limited and yields a number of false negatives as several markers often fall
below the cut-oﬀ level. Genes often interact to perform some biological
function in a cell which can lead to a speciﬁc phenotype. It is likely that
many markers or genes singularly with low or moderate risk may interact to
produce a signiﬁcant combined eﬀect for complex diseases, such as TB. This
suggests that analyzing genes at the systems level based on protein-protein
functional interaction networks may help understand better the etiology of a
disease and elucidate genetic factors inﬂuencing the disease pathogenesis.
Mathematically, protein-protein functional interaction networks are
represented by undirected graphs with proteins as nodes and functional
interactions (connections) between proteins as edges or links. In this study,
we use a model that integrates GWAS data from a given population
(admixed or homogeneous), with the human and MTB protein-protein
interaction network to predict sets of genes that interact to investigate
predisposition to a disease for individuals in a given population.
In this chapter, we provided details on the integrated scoring scheme used
to produce uniﬁed networks integrating interaction datasets from a variety of
sources. We also discuss network centrality measures to score the relevance
of proteins in the network and examine other topological properties of the
biological networks. These biological networks are often modular in nature,
indicating that some proteins in the network are more essential or central than
others. Finally, we describe a sub-graph ﬁnding (clustering) algorithm that is
used to identify key sub-graphs associated with disease risk and methods used
to elucidate the most signiﬁcant processes and pathways implicated in the
disease and for combining eﬀects of diﬀerent SNPs and ancestry contribution
within each gene. Throughout this chapter, G = (N,L) represents the undi-
rected graph where N is the set of interacting proteins (nodes) and L is the
19
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set of functional interactions (links or connections) between proteins in the
system.
3.1 Building uniﬁed networks and centrality
measures
Protein-protein interaction datasets are derived from diﬀerent sources. De-
pending on the source, these interactions are scored as these datasets are often
noisy and unreliable. For a given interaction, this conﬁdence score is simply
the probability that the interaction occurs and this depends on data source
and technology used. Thus, each interaction dataset produces a graph with
weighted relationships between each protein pair. Integrating these diﬀerent
datasets into a uniﬁed network increase coverage and reduce the likelihood
of a false negative. Thus, an integrative scoring scheme is necessary to pro-
duce an integrated protein-protein functional interaction data from a variety of
sources to generate a complete interaction network. In this thesis, we generate
the human, MTB strain CDC1551 and human-MTB protein-protein functional
interaction networks as summarized in Figure 3.1.
Figure 3.1: Summary of diﬀerent protein-protein functional interac-
tion datasets. Integration of protein-protein functional interactions derived
from diﬀerent sources into a uniﬁed functional network
.
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3.1.1 Integrative interaction scoring function and
eﬀectiveness
The reliability or conﬁdence score of an interaction between proteins p and q
quantiﬁes how reliable is this speciﬁc interaction and represents the probability
that this interaction occurs. Assume that n diﬀerent sources were used to
predict this interaction and let Epq be an event indicating that the functional
interaction between proteins p and q could not be inferred from any of these
n sources under consideration, that is:
Epq =
n∩
=1
Epq (3.1.1)
with Espq the event indicating that the functional interaction could not be re-
trieved using the source s. Under the assumption that sources are independent,
the probability P
(
Epq
)
of the event Epq is given by:
P
(
Epq
)
= P
(
n∩
=1
Epq
)
=
n∏
=1
P
(
Epq
)
=
n∏
=1
(
1− P (Epq))
(3.1.2)
where Epq is the event indicating that the functional interaction is retrieved
using the source s and thus P
(
Epq
)
= spq with s

pq the conﬁdence score of a
functional association between p and q predicted using the source j. Thus, the
combined conﬁdence score Spq for interacting proteins p and q, which is the
probability of the event Epq, which indicates that the functional interaction
between proteins p and q can be inferred from at least one of the sources,
contrary to Epq, is given by:
Spq = P (Epq)
= 1− P (Epq)
= 1−
n∏
=1
(
1− P (Epq)) . (3.1.3)
It follows that:
Spq = 1−
n∏
=1
(
1− spq
)
(3.1.4)
under the assumption of independency.
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Finally, one may choose to use other scoring functions, such as minimum
(min), maximum (max) and average (mean) of diﬀerent conﬁdence scores,
however, these produce biased combined or uniﬁed scores. Let us assume
that out of n = 5 diﬀerent data sources for human, the functional interaction
between proteins p and q was predicted from 2 sources out of 5 with
conﬁdence scores of 0.200 and 0.130. So, for any other source, the conﬁdence
score is assumed to be 0, and it follows that:
 Using the min function, we get Spq = min
{
0.00, 0.00, 0.00, 0.200, 0.130
}
,
which implies that Spq = 0.00, indicating that the conﬁdence score is 0 and
this interaction will be ignored in diﬀerent analyses whereas it was predicted
by two diﬀerent sources.
 Using max and mean, the combined conﬁdence score, Spq, is equal to 0.200
and 0.066, respectively. The max function does not reﬂect the fact that the
functional interaction was predicted from two diﬀerent sources and the mean
function reduces our conﬁdence level. Intuitively, as this interaction was
predicted by two diﬀerent sources, one expects its conﬁdence level to
increase, but instead it is decreasing. This suggests that these scoring
functions are not in agreement with what can be expected and show biases
by underestimating combined interaction scores in the ﬁnal network. On the
other hand, using the scoring function in equation (3.1.4) as used in this
study, we have Spq = 0.304, showing more realistic combined conﬁdence score
compared to other scoring functions, and is in agreement with what one
would expect.
In the context of this study, the combined conﬁdence score values are cate-
gorized into three diﬀerent conﬁdence levels: low (score < 0.3), medium (0.3
≤ score ≤ 0.7), and high (score > 0.7). Interactions with scores lower than
0.3 are considered to be low conﬁdence, interactions with scores range from
0.3 to 0.7 are classiﬁed as medium scored, and interactions with score greater
than 0.7 are said to be high conﬁdence interactions. In order to minimize
the number of false positives and produce a reliable uniﬁed protein-protein
functional interaction networks, we only consider interactions in the medium
or high conﬁdence categories and those which are predicted by at least two
diﬀerent sources.
3.1.2 Network centrality measures
Network centrality measures are used to numerically characterize the impor-
tance of proteins in the network. We use these measures to examine the criti-
cality of a protein in a given network. These centrality measures include degree
or connectivity, betweenness, closeness, and eigenvector centrality. Note that
a path between two proteins p0, pı ∈ N in a protein-protein functional network
G(N,L) is a sequence of adjacent proteins p0, p1, . . . , pı−1, pı ∈ N leading from
p0 to pı. The number of edges in a path is called path length measuring the
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distance between two proteins in networks. The mean or characteristic path
length of a graph G is the average path length of shortest paths between all
pairs of proteins (Barabasi and Oltvai, 2004), and when a network has a low
mean path length, the network is said to satisfya small world property.
3.1.2.1 Degree centrality
Given a protein v in a network, the degree centrality Cd(v) = deg(v) of v is
deﬁned as the number of other proteins it interacts with. The degree of a
protein node v tells us the number of links the protein has to other proteins
and it is given by Mazandu and Mulder (2011a)
deg(v) =
∑
u∈N
δ(v, u), (3.1.5)
where
δ(v, u) =
{
1 if the protein u is functionally linked to the protein v,
0 otherwise.
deg(v) is the number of proteins interacting with v. Degree centrality of a
node is used to characterize the importance of the node in the network. A
protein which has many functional connections is said to be a key protein as it
may has contributions to many important processes in the system (Mazandu
and Mulder, 2011a).
3.1.2.2 Closeness centrality
The closeness centrality Cc(v) of a protein v in a connected graph G is the
inverse of its status, that is the inverse of the average shortest distance to all
other proteins connected to it. For a given network, the normalized closeness
centrality of a protein v in the network is given by Mazandu and Mulder
(2011a):
Cc(v) =
nc − 1
(Lc − 1)× S(v) , (3.1.6)
where |Nv| = nc is the number of proteins in the connected component of the
graph containing the protein node, Lc is the number of functional links in the
connected component, and S(v) is the status of v relative to its connected com-
ponent, which is the average shortest distance to all other proteins connected
to v, given by:
S(v) =
1
nc − 1
∑
u∈Nv
γvu, (3.1.7)
where Nv is the set of proteins interacting with v, nc = |Nv| is the number of
nodes in Nv and γvu is the shortest path length between v and u in the
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network.
The closeness measure indicates the importance of a protein in such a way that
an important protein node is typically close to and can communicate quickly
with, the other proteins in the network.
3.1.2.3 Betweenness centrality
This centrality measure reveals the importance of a protein in the system
when it is not highly connected. It shows the importance of a protein for
transmission of information between other two node proteins in the network.
This measure can be used to identify non-hub proteins that are important in
the system or to classify hubs according to their positions in the
network (Bonacich, 2007).
The betweenness centrality of the protein v in a functional network is deﬁned
as the sum of the ratio of the number of shortest paths passing through the
protein to the total number of shortest paths in the functional network. The
betweenness centrality, Cb(v), of the protein v is given by
Cb(v) =
∑
s6=v 6=t
σst(v)
σst
, (3.1.8)
where s and t are proteins in N diﬀerent from v, σst(v) denotes the number
of shortest paths from protein s to protein t passing through v, and σst is the
number of shortest paths from s to t.
The normalized betweenness value (0 ≤ Cb(v) ≤ 1) of the protein v is obtained
by dividing by the number of protein pairs excluding v
Cb(v) =
2
(n− 1)(n− 2)
∑
s6=v 6=t
σst(v)
σst
, (3.1.9)
n = |N | is the number of proteins in the network.
3.1.2.4 Eigenvector centrality
The eigenvector centrality measure assigns weight or importance to proteins
based on their functional connections. Proteins functionally connected to im-
portant proteins are more inﬂuential than proteins connected to less important
proteins (Mazandu and Mulder, 2011a). Let Ci be the contribution or weight
of a protein i in the network. (Bonacich, 2007) Let A = (aij)1≤i,j≤n be the
adjacency matrix of the network, where aij = 1 when proteins i and j are
functionally connected and aij = 0 if they are not connected. The eigenvector
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centrality Ci of a protein i is deﬁned as
Ci =
1
λ
∑
j∈N
aijCj, (3.1.10)
where λ is the largest eigenvalue of A. That is, AC = λC where
C = (c1, . . . cn)
T is the eigenvector of A associated with the eigenvalue λ, the
transpose of a vector that deﬁnes the contribution of each protein in the
network.
In this measure the importance of a protein depends on the quality of its neigh-
bours rather than the number of its interaction. A protein with high degree
centrality may has less eigenvector centrality value than a protein connected to
few, but important nodes and it may has high contribution to the functioning
and survival of the system.
3.1.3 Degree Distribution of proteins in the functional
network
The connectivity or degree distribution, P(k), is the probability that a selected
protein is connected to k proteins (of degree k) in the network. P(k) is approx-
imated by the frequency of occurrence of protein of degree k in the network,
given by
P(k) =
nk
n
(3.1.11)
where nk is the number of nodes with degree k, k = 1, 2, 3, . . . and n the total
number of nodes in the network. Networks can be categorized in two classes
based on their degree distribution (Zhang, 2009), namely random and
scale-free networks.
Random networks have a degree distribution, P(k), that follows a poisson
distribution. This network is homogeneous, in that most proteins have roughly
the same number of links. These networks are characterized by a P(k) that
peaks at an average < k > and decays exponentially for large k (Albert et al.,
2000). Scale-free networks, in contrast, are heterogeneous. That is, they have
few nodes with many interactions and many nodes with few interactions. The
number of links of a given node approximates a power law model, for which
P(k) decays as a power-law, that is
P(k) ∼ k−γ, (3.1.12)
where the power exponent γ is a constant characteristic of the network. This
distribution is independent of the number of nodes, thus the networks are
said to be scale free. Albert et al. (2000) indicated that the probability that
a protein has a large number of links, i.e., the degree larger than the mean
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degree of all proteins in the network (k >>< k >), is small in scale-free
networks and highly connected proteins (hubs) are essential and play
signiﬁcant role in scale-free networks.
Recent studies have shown that many biological networks are scale-free. Thus
their degree distribution approximates power law, indicating that most pro-
teins participate in only a few interactions, while a small set of hubs participate
in many interactions (Zhang, 2009; Wagner, 2003; Albert et al., 2000). It is ob-
served that networks that have scale-free topological properties have a higher
error tolerance or resistance to random node failure. The ability of their nodes
to communicate being unaﬀected even by unrealistically high failure rates (Al-
bert et al., 2000). But they are very vulnerable to the selection and removal
of the few nodes that play a major role in maintaining the network's connec-
tivity. Albert et al. (2000) demonstrated the diﬀerence between the random
and scale-free networks as shown below in Figure 3.2. Both networks have 130
Figure 3.2: Graphical illustration of the diﬀerence between an exponential and
a scale-free network (Albert et al., 2000)
nodes and 215 links (< k >= 3.3). The ﬁve red nodes are the nodes with
the highest number of links and the green nodes are their ﬁrst neighbours. In
the exponential network only 27% of the nodes are reached by the the ﬁve
red nodes, but in the scale-free network 60% of the nodes are reached showing
the importance of the most connected nodes. This shows that in these net-
works, nodes that are highly connected are important in the maintenance of
the system.
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3.1.4 Identifying network key proteins
The three degree centrality measures; degree, betweenness, and closeness cen-
trality values are used to determine the key proteins or hubs in the functional
network, in which case, these centrality values reach a certain threshold. For
degree centrality measure, the threshold is mean degree centrality, mean(Cd).
For betweenness measure, the threshold is the total number of shortest paths
expected in the network, which is given by n × pi, where n is the number of
nodes in the network and pi is the average shortest path length. The cut-
oﬀ for closeness centrality measure is 1
pi
, the inverse of the average shortest
path length. A protein v in a network is a key protein if Cd(v) ≥ mean(Cd),
Cb ≥ n× pi and Cc(v) ≥ 1pi .
3.2 Network proteins clustering
Classifying proteins in human and pathogen functional networks can help un-
derstand biological mechanisms underlying the system in the study, we identify
the densely connected sub-networks or communities of functional network. We
perform functional analysis of clusters or communities containing key proteins
and important candidate proteins of the two population groups under consid-
eration. This may enable the discovery of hidden information in the complex
network, such as the diﬀerence between the admixed and homogeneous popula-
tion regarding susceptibility to disease. There exist diﬀerent community detec-
tion methods for identifying community structures in complex networks with
the quality of the communities being measured by their `modularity' (Stein-
haeuser and Chawla, 2010; Blondel et al., 2008). Here we used the Blondel
et al. (2008) method, which was shown to perform better than other meth-
ods (Blondel et al., 2008), to partition diﬀerent functional networks in order
to detect connected sub-networks/communities.
3.3 Combining p-values at gene level
GWAS is not suﬃcient in itself to reveal the genetic structure of complex
diseases considering the multiple genetic and environmental factors
contributing to development of a complex disease, such as TB. Thus,
considering the combined eﬀects of genes by detecting genetic signals beyond
single gene polymorphisms provides increased potential to fully characterize
the susceptible genes and the genetic structure of complex diseases.
In the uniﬁed human network, GWAS SNPs and their p-values retrieved from
literature are mapped to their corresponding genes in the network. We com-
bined SNP eﬀects at gene level using their p-values from the genome wide
association studies (GWAS). We used the Liptak-Stouﬀer Test to assess the
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signiﬁcance of genes disease association and to discover possible novel risk
genes in the network (Chimusa et al., 2015). Stouﬀer's test changes the p-
values in to standard normal distribution and performs a z-test. Under as-
sumption that pi (i = 1, 2, . . . , n) are independent p-values of SNPs associated
with a gene and that these p-values follow a standard normal distribution,
let φ be the cumulative distribution function of standard normal distribution
(N(0, 1), i.e, with mean 0 and standard deviation 1) deﬁned in equation 2.3.5,
and qi = φ
−1(1−pi) quantiles derived from 1−pi. Then, the Liptak's combined
p-value statistic, Cp, is given by
Cp =
∑n
i=1 qi√
n
which follows the standard normal distribution N(0, 1) and the related com-
bined p-value is p∗ = 1− φ (Cp).
3.4 Combining local ancestry at gene level in
admixed population
For the admixed South African Coloured (SAC) population, we estimated
the local ancestry contribution for each of the source population at gene
level. Then we investigated ancestry-speciﬁc disease risk in the population to
identify the ancestries that are correlated to the disease susceptibility. We
combined locus speciﬁc ancestry contribution of SNPs within a gene to
estimate gene speciﬁc ancestry contribution. The gene-speciﬁc ancestry from
the speciﬁc ancestral population is estimated using the maximum likelihood
approach.
For a given gene j. Let φmk be the average locus-speciﬁc ancestry of SNP
m ∈ {1, 2, . . . , n} from the kth ancestral population associated with gene
j, (j = 1, 2, . . . , J). Consider each φ1k, φ2k, . . . , φnk as n independent and iden-
tically distributed observations. Assume that each observation φmk can be
approximated as a normal distribution under natural drift with mean 0 and
empirical variance Vmk and inverse variance Wmk. Let µjk be the unknown
true gene-speciﬁc ancestry of gene j from the kth ancestral population. We
estimate the maximum average likelihood of the observations (Chimusa et al.,
2015), µˆjk by solving the following system of equation equation
∂L
∂µjk
(µjk, Vmk;φ1k, φ2k, . . . , φnk) = 0
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with L(µjk, Vmk;φ1k, φ2k, . . . , φnk) the likelihood function given by
L(µjk, Vmk;φ1k, φ2k, . . . , φnk) =
n∏
m=1
1√
2piVmk
exp
(
−(φmk − µjk)
2
2Vmk
)
and the maximum likelihood estimate, µˆjk is a weighted sum of the SNPs
locus-speciﬁc ancestry using precision (inverse-variance) weights divided by
the sum of the precision, given by
µˆjk =
∑n
m=1Wmkφmk∑n
m=1Wmk
(3.4.1)
with variance, Vˆjk, given by:
Vˆjk =
1∑n
m=1Wmk
. (3.4.2)
Given a gene or protein j in the network, we have the gene speciﬁc ancestry
contribution estimate µˆjk (k = 1, . . . , 5) with variance Vˆjk of each population
ancestry in SAC. To identify ancestries showing unusual gene speciﬁc ancestry
contributions, we start by ranking diﬀerent ancestors with a gene using their
contribution scores. The ranked ancestor list is then used to compute a Pearson
χ2 score (Mazandu and Mulder, 2011b) or Pearson's cumulative test statistic
for each ancestor subset, reﬂecting the tendency of ancestors in a particular
set to occur towards the extremes of the list. The Pearson χ2 score of a subset
containing ancestors in the ranked list re-indexed from m to `, χ2P (m, `), is
given by:
χ2P (m, `) =
∑`
k=m
(µˆk − µm`)2
µm`
(3.4.3)
which is known to asymptotically approximate a χ2-distribution with ` − m
degree of freedom (dof), i.e., of variance 2 ∗ (` − m) and where µm` is the
expected value and represents aggregated score (ES) of the extracted subset
and estimated as follows:
µm` = ES (`−m+ 1) =
∑`
k=m
µˆk (3.4.4)
The ancestries showing unusual gene speciﬁc ancestry contributions are sˆ top
ancestors with sˆ the index fold-change Pearson χ2 score. Assuming that the
ranked list contains n proteins, sˆ (sˆ ≤ n) is the smallest index satisfying the
following inequality:
χ2P (1, sˆ)− r ∗ χ2P (sˆ+ 1, n)√
1 + r2
> 0 (3.4.5)
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where
r =
√
sˆ− 1
n− sˆ− 1 (3.4.6)
which is simply the ratio of standard deviations of χ2P (1, sˆ) and χ
2
P (sˆ+ 1, n),
and set to 1 if sˆ=1.
The signiﬁcance of the aggregated score, ES (sˆ), of ancestries showing unusual
gene speciﬁc ancestry contributions is assessed using sample randomization.
We randomly select 1000 independent subsets (of same size sˆ) of ancestry
contributions and compute ES of each subset and then perform the Shapiro-
Wilk test under the null hypothesis that the generated sample is drawn from
a normal distribution. Following the acceptance or the rejection of the null
hypothesis, we perform the T-test or the Wilcoxon to check whether identiﬁed
ancestries showing unusual gene speciﬁc ancestry contributions is more than
expected by chance.
3.5 Measuring proteins closeness at the
functional level
Proteins perform an astonishing range of biological functions in an organism
by collaborating in pathways and processes, and interacting with the cellular
environment in some way to promote the cell's growth and function (Mazandu
and Mulder, 2011a; Mulder et al., 2014). This argues that the outcome of
the disease or response to drugs requires concerted biological action of many
genes involved in diverse processes or signalling pathways. Here, we use func-
tional data from the Gene Ontology (GO) and the protein GO Annotation
(GOA) to score putative proteins which are functionally similar, quantifying
functional similarity between proteins based on their GO biological process
annotations. Given two proteins p and q, the functional similarity between p
and q, BMA(p, q), is computed using the Best Match Average model (Mazandu
and Mulder, 2012a, 2013b, 2014a) as follows:
BMA(p, q) =
1
2
 1
n
∑
s∈Tp
S (s, Tq) + 1
m
∑
s∈Tq
S (s, Tp)
 (3.5.1)
where Tr is a set of process terms annotating a given protein r and n = |Tp|
and m = |Tq| are the number of processes terms in these sets. S (s, Tr) =
max {S (s, t) : t ∈ Tr} with S (s, t) is the semantic similarity score between
process terms s and t computed using the GO-universal metric Mazandu and
Mulder (2012a), and given by:
S (s, t) = IC(c)
max {IC(s), IC(t)} (3.5.2)
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where IC(x) is the information content of the term x in the GO DAG and c is
the most informative common ancestor between s and t. The IC value of the
term is given by:
IC (x) = − ln (p (x)) (3.5.3)
p(x) is called the topological position characteristic of x, recursively obtained
using its parents gathered in the set Px = {t : (t, x) ∈ LGO} where LGO ex-
presses the set of links in the GO-DAG and (t, x) ∈ LGO represents the link or
association between a given parent t and its child x. This topological position
characteristic, p(x), is given by
p (x) =

1 if x is a root,∏
t∈Px
p (t)
|Ch(t)| otherwise
(3.5.4)
with |Ch(t)| the number of children with term t as parent.
3.6 Retrieving enriched processes and
pathways of targets identiﬁed
We used the Gene Ontology (GO) and the protein GO Annotation (GOA)
mapping provided by the UniProtKB-GOA project to reveal enriched pro-
cesses in which a set of protein targets are involved. For elucidating sta-
tistically signiﬁcant pathways implicated to the disease, we used the KEGG
pathway dataset to extract all human pathways. For each GO term process
and pathways, the p-value was calculated using its frequencies of occurrence
in the reference dataset (human proteome) and target set, which composed
of identiﬁed protein targets, and adjusted using the Bonferroni multiple test-
ing correction. We used the hyper-geometric distribution, the p-value is the
probability of observing at least s proteins from a target gene set of size n by
chance, knowing that the reference dataset contains m annotated genes out of
N genes. This is given by the following formula (Mazandu and Mulder, 2013a):
P [X ≥ s] = 1−
s−1∑
k=0
(
m
k
)(
N −m
n− k
)
(
N
n
) (3.6.1)
where the random variable X is the number of genes annotated with the GO
term under consideration within a given disease-associated gene subset. To
account for relationships between GO terms in the GO structure, we used
the concept of the GO term semantic similarity score (Mazandu and Mulder,
2013a) and the frequency of occurrence f (t) of the target-associated process
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t in a set of proteins P is given by:
f (t) =
∑
q∈P
δq (t) (3.6.2)
where δq is the q−function indicator given by
δq (t) =
{
1 if Aq (t) > ε
0 otherwise
(3.6.3)
where ε ≥ 0 is the agreement level or customized agreement at which a GO
term is considered to be a possible annotation of the protein q and Aq (t) =
S (t, Tq), representing the semantic similarity degree at which a related term is
considered to semantically reﬂect in the speciﬁcation of the term t (Mazandu
and Mulder, 2014b). The p-value of each process term was adjusted using the
Bonferroni multiple testing correction.
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Results and discussion
To analyze susceptibility to tuberculosis (TB) at the systems level, we start by
constructing intra- and inter-organism protein-protein functional interaction
networks (human, MTB strain CDC1551 and human-MTB). In this chapter,
we used computational methods described in the previous chapter to inte-
grate diﬀerent protein-protein interaction datasets in order to generate uniﬁed
networks and map diﬀerent targets/markers identiﬁed into these networks to
assess the contribution of each target/marker to the system using network cen-
trality measures. Moreover, we checked whether these targets are related by
interacting in the map, belonging to the same cluster or being closely related
based on GO processes annotating them. Since targets or markers, especially
those associated with a speciﬁc phenotype, may diﬀer between individuals or
populations, but may be involved in the similar processes or work together in
the same pathway, we also performed functional analyses of diﬀerent targets,
identifying enriched processes and pathways in which diﬀerent markers are
involved.
4.1 General topological structure of uniﬁed
functional networks
In this section, we present general features and topological properties of dif-
ferent functional networks generated. It is worth mentioning that in diﬀerent
analyses, interactions with low conﬁdence scores (between 0 and 0.3) were dis-
carded unless they are predicted by at least two diﬀerent sources. For the MTB
strain CDC1551, we have predicted a total of 138429 functional interactions
(edges) connecting 4170 proteins in the complete set of all 4201 proteins from
the UniProt database. The human functional network is comprised of 2878644
functional interactions connecting 19274 proteins in the set of 20199 human
reviewed proteins as read from the ﬁle retrieved from the UniProt database.
Diﬀerent predicted interactions were categorized in three classes, namely low,
33
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medium and high conﬁdence interactions and summarized in Table 4.1 and
diﬀerent general features of each network are shown in Table 4.2.
Table 4.1: Predicted protein-protein functional interactions. Func-
tional interactions in diﬀerent networks shown separately for each dataset per
conﬁdence range. `-' indicates that a source was not used because of lack of data
for the organismes under consideration. `Other' source is speciﬁcally related to
human-MTB interactions extracted from interolog-DIP-known, interolog-DIP
array and interolog-HPI-array (Rapanoel et al., 2013).
Data source
Low Medium High
Human MTB Human-
MTB
Human MTB Human-
MTB
Human MTB Human-
MTB
STRING 2591298 165668 - 729973 62780 - 283776 14340 -
Sequence data 517331 193 0 447354 26220 7260 1484883 40510 303
Interologs - - 0 - - 0 - - 92
DIP 0 - - 0 - - 61865 - -
Intact 0 - - 0 - - 4714 - -
Others - - 0 - - 0 - - 608
Combined score 2931698 159943 0 1104684 84133 7260 1773958 54286 552
In MTB functional network, we identiﬁed 10 interactions with low conﬁdence
scores, but predicted by at least two diﬀerent sources. The human and MTB
functional networks were analyzed for general properties of the degree and
path-length distributions and results are shown in Figures 4.1 and 4.2.
Table 4.2: General network parameters. Features of diﬀerent functional
networks in terms of number of proteins and functional interactions connecting
them, as well members of connected components where possible.
Features
Value
Human MTB Human-MTB
Number of interactions 2878644 138429 7868
Number of proteins 19274 4170 2095
Number of human proteins - - 225
Number of CDC1551 proteins - - 103
Number of components 52 23 197
4.1.1 Fitting degree and path-length distribution
Degree distribution: The result in Figures 4.1 shows that these functional
networks satisfy scale-free topology properties, i.e., the degree distribution of
proteins approximates a power law function P(k) = k−γ , with the degree
exponents γ ∼ 1.34506, and 1.28124 for MTB and human, respectively.
These degree exponent values were determined using the linear model:
log (P(k)) ∼ −γ log(k), linear in log, with p-values < 2e − 16 for human and
MTB functional networks, respectively, under the null hypothesis that γ = 0.
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Figure 4.1: Protein connectivity or degree distribution in MTB and
human functional networks. Circle mortar represents the frequency P(k)
of observing a protein interacting with k partners in a functional network.
The solid line plots the power-law function approximating the connectivity
distribution.
This means that the observed data shows evidence that these power
exponent values are signiﬁcantly diﬀerent from 0. This means that although
some of the proteins would have many interacting partners, most of them
would have few partners. The proteins that have many interacting partners
are called "high degree" proteins or hubs or key proteins and probably ensure
some basic chemical operations, such as energy transfer and redox reactions,
essential for the survival of the organism (Albert et al., 2000).
Path-length distribution: The average path lengths are approximately 3
(hops) for MTB and human functional networks, respectively, indicating that
the spread of biological information in these systems is relatively fast. The
two functional networks have a "small world" property, i.e, the transmission
of biological information from a given protein to others is achieved through only
a few steps. This provides an idea about the network navigability, indicating
how fast the information can be spread in the system independently of the
number of proteins (Albert et al., 2000). Since MTB must survive in the host,
this property may provide it with an evolutionary advantage in the sense that
it would be able to eﬃciently respond to the perturbations in the environment
and to quickly exhibit a qualitative change of behaviour in response to these
perturbations. This is important, as MTB may be forced to react in response
to host antibacterial immune mechanisms in order to promote its entry and
replication into the host cell.
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Figure 4.2: Path-length distribution in MTB and human functional
networks. Histogram plot represents the path-length distribution, i.e, fre-
quency of occurrence of shortest path of length `, ` = 1, 2, 3, . . . and the dashed
line plot is the normal distribution approximating the path length distribution.
4.1.2 Identiﬁcation of network key proteins and
clustering results
Revealing the hierarchical community structure of the networks, identifying
key proteins and mapping disease associated genes or proteins onto uniﬁed
functional networks can provide a better understanding of the disease
pathogenesis and increased potential to fully characterize the susceptible
genes. In the human system, 2878644 interactions out of a total of 5810340
predicted functional interactions in the uniﬁed network with scores ranging
from medium to high conﬁdence level were used. We identiﬁed 915 key
proteins out of 19274 found in the human protein-protein functional network
representing about 5% of interacting proteins in the human protein-protein
functional interaction network. The clustering model described in section 3.2
splits this human networks into 52 clusters or densely connected
communities, the biggest or giant cluster containing 4385 proteins, of which,
122 are key proteins. Among the 52 modules or clusters in the network, only
9 of the clusters contain key proteins and the distribution of these key
proteins as shown in Table 4.3.
For the pathogen system, only 138429 out of 172108 protein-protein functional
interactions (edges) connecting 4170 proteins have interaction scores ranging
from medium to high conﬁdence scores (scores greater than 0.3) or identiﬁed
by at least two diﬀerent sources, and used for further analyses. In this network,
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Table 4.3: Classiﬁcation of human proteins in the functional network.
Distribution of proteins and key proteins in 9 diﬀerent clusters.
Cluster number Number of proteins Number of key proteins
0 4385 122
1 1333 29
2 4233 323
3 2890 102
4 925 30
5 1941 9
6 987 60
7 1188 159
8 1288 81
Total 19170 915
we have identiﬁed 22 clusters or communities, the giant cluster contains a total
of 907 proteins. Using the threshold value given for key proteins, there are 1095
key proteins in the MTB network.
4.2 Tuberculosis risk genes in diﬀerent
populations
A SNP-gene mapping ﬁle was downloaded from the International Haplotype
Map Phase 3 website (Frazer et al., 2007) at http://hapmap.ncbi.nlm.nih.
gov/. SNPs were mapped to their corresponding genes in the human func-
tional network based on the SNP-gene distance. Among these SNPs, 112 and
122 SNPs with moderate p-value (≤ 5× 10−5) in SAC (Chimusa et al., 2014)
and Ghana-Gambia (Thye et al., 2010) population, respectively, were retrieved
from literature. There is no SNP shared between the admixed and homoge-
neous populations. From the human functional network, 18813 proteins were
found in the SNP-gene mapping ﬁle, of which, 15 and 52 proteins have SNPs
with moderate p-values and belong to SAC and Ghana-Gambia populations,
respectively. No common gene is shared between the two populations.
4.2.1 Identiﬁcation tuberculosis risk genes
To identify TB risk genes or candidate genes, we combine the eﬀect of all
SNPs that did not reach the intrinsic genome-wide signiﬁcance threshold
p-value of 5 × 10−8, but with moderate p-values within a particular gene
using the approach described in section 3.3. 6 proteins out of 15 in SAC
population and 8 out 52 in Ghana-Gambia met the intrinsic genome-wide
signiﬁcance threshold p-value and are believed to be disease causing genes
(disease candidate genes) or to make populations under consideration to be
genetically susceptible to TB. These signiﬁcant disease associated genes with
their associated moderate SNPs and distances are shown in Table 4.4.
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The 6 disease associated genes with signiﬁcant combined p-value are
A3KMH1, Q7Z5N4, Q6ZVL6, Q9NQ90, P19544, and Q8NEX9. These genes
are involved in diﬀerent processes and have diﬀerent functions in the human
system. The details about the proteins and their function can be found in
the UniProt website (http://www.uniprot.org/). For instance, A3KMH1
has two GO-molecular functions; ATPase activity, which contributes the
catalysis of the reaction: ATP + H2O = ADP + phosphate + 2 H+. It is an
enzyme or a catalytic protein in ATP cycle through which energy passes
during its transfer from catabolic to anabolic pathways. The other
biochemcal activity of this gene is ATP binding, interacting selectively and
non-covalently with ATP, adenosine 5'-triphosphate, a universally important
coenzyme and enzyme regulator. This protein can be attacked and used by
the pathogen to weaken the host system as it is important in energy release
and consumption process.
Similarly, we get the set of disease associated genes in the homogeneous Ghana-
Gambia population with their associated moderate SNPs and distances, see
Table 4.4. The 8 signiﬁcant disease associated genes are Q9BQI5, P32245,
Q86Y38, A1KZ92, Q07020, Q5T5C0, Q8TEW8, and O60669. The details and
functions of these proteins can also be found at the UniProt website (http:
//www.uniprot.org/). For example, the disease associated gene Q9BQI5 has
3 GO-molecular function and 6 GO-biological processes annotated to it.
4.2.2 Quantifying SAC ancestral contributions to TB
susceptibility
We combined the SAC true locus-speciﬁc ancestry contribution retrieved
from (Chimusa et al., 2014) within each candidate gene using the model
described in section 3.4 in order to elucidate the ancestor contributing to TB
susceptibility in this admixed population. The South African Coloured
(SAC) population is an admixed population group in South Africa which has
a high incidence of TB. The population is a mixture of ﬁve populations;
isiXhosa(YRI), Khomani SAN (KHS), European (CEU), Indian (GIH), and
Chinese (CHS). By combining the local ancestry contribution of GWAS
SNPs at gene level, we elucidated the ancestry which confers TB disease
susceptibility to the SAC population.
We took the 6 SAC disease genes and combined their SNPs local ancestry
contribution to the corresponding genes ancestry proportion of each ancestor
using maximum likelihood estimation as shown in Table 4.5. Looking for the
ancestry with high statistical signiﬁcance in each disease gene, we found that
African ancestor Khomani San (KHS) has high contribution in all the disease
genes with p-values < 2e − 16. This means this ancestor contributes highly
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Table 4.4: Diﬀerent disease associated genes identiﬁed. Signiﬁcant dis-
ease associated proteins of the admixed SAC (in the ﬁrst part) and homoge-
neous Ghana-Gambia populations (in the second part) with their descriptions
(name), cluster in which they are mapped (Cluster Ref), associated moderate
SNPs and distances.
ID Name Gene
name
Cluster
Ref
Total
SNPs
Closest
SNPs
SNPs Distance P-value Combined
P-value
A3KMH1 von Willebrand factor
A domain-containing
protein 8
VWA8 7 306 219 rs9525555
rs1900442
0
0
5.72115e-06
3.00952e-06
1.46047e-10
Q7Z5N4 Protein sidekick-1 SDK1 6 989 746 rs12701526
rs1542222
4313
5356
8.10041e-06
2.48252e-06
1.71852e-10
Q6ZVL6 UPF0606 protein
KIAA1549L
KIAA1549L 3 165 105 rs4755689
rs12273774
rs6484655
18621
22713
47656
3.24968e-07
2.92121e-06
6.41033e-06
5.81170e-16
Q9NQ90 Anoctamin-2 ANO2 4 351 315 rs12426185 0 4.44541e-08 4.44541e-08
P19544 Wilms tumor protein WT1 8 135 42 rs11031731
rs10767930
rs7924866
rs11031714
rs7928458
43891
47636
58969
67298
81257
2.6962e-06
7.2745e-06
1.67123e-06
1.00134e-06
3.02134e-06
9.77582e-25
Q8NEX9 Short-chain dehydro-
genase/reductase fam-
ily 9C member 7
SDR9C7 0 63 18 rs1872436
rs719750
rs7970701
rs840160
0
0
0
0
1.05439e-10
3.74505e-09
3.74505e-09
3.74505e-09
1.12956e-32
Q9BQI5 SH3-containing
GRB2-like protein
3-interacting protein
1
SGIP1 1 311 202 rs10493412
rs12141816
rs17436311
0
0
0
5.58e-05
5.73e-05
5.17e-05
1.04617e-11
P32245 Melanocortin receptor
4
MC4R 2 258 3 rs7236588
rs1943238
rs1943240
70882
75228
76434
1.36e-05
8.7e-05
8.39e-06
7.48991e-13
Q86Y38 Xylosyltransferase 1 XYLT1 5 556 227 rs7197476
rs7190310
rs1542421
0
0
0
4.46e-05
7.61e-05
5.43e-05
1.16627e-11
A1KZ92 Peroxidasin-like pro-
tein
PXDNL 6 415 325 rs1837087
rs7844531
rs6986651
rs4873534
5674
12506
13020
43923
1.52e-05
8.45e-06
8.45e-06
1.17e-05
9.28385e-18
Q07020 60S ribosomal protein
L18
RPL18 0 191 3 rs1353690
rs904263
250064
256730
1.83e-05
5.43e-05
7.75686e-09
Q5T5C0 Syntaxin-binding pro-
tein 5
STXBP5 7 153 54 rs9373523
rs4896905
0
0
1.23e-06
3.22e-05
3.70374e-10
Q8TEW8 Partitioning defective
3 homolog B
PARD3B 2 813 646 rs2335704
rs2335705
rs13390761
0
0
0
4.63e-06
4.59e-06
2.73e-05
9.28385e-18
O60669 Monocarboxylate
transporter 2
SLC16A7 5 445 99 rs2175950
rs11173067
rs10877268
69438
166303
307062
1.79e-05
3.32e-05
8.54e-05
3.46121e-12
to TB susceptibility in the population. This fact agrees with other results
that the African ancestry of the SAC population has higher risk of TB infec-
tion (Daya et al., 2014a). It is worth mentioning that the fact that the genetic
Table 4.5: Gene level ancestry contribution in SAC disease associated
genes. Combining ancestry speciﬁc TB risk at gene level in the SAC popula-
tion to predict ancestries conferring disease risk to this admixed population.
Gene KHS GIH CHS YRI CEU
A3KMH1 0.49658 0.00110 0.00034 0.00170 0.0
Q8NEX9 0.73704 0.01841 0.12653 0.00699 0.0
Q7Z5N4 0.98908 0.00614 0.00477 0.0 0.0
Q6ZVL6 0.93727 0.01569 0.33856 0.10504 0.00182
Q9NQ90 0.93315 0.01296 0.00068 0.01568 0.00477
P19544 0.76862 0.02032 0.10463 0.03492 0.00436
contributions of diﬀerent ancestries with a gene do not sum to 1 provides an
indication that the genetic component does not fully explain susceptibility to
the disease. This means that the environment factors, including life style, may
also contribute to TB susceptibility in this population.
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4.2.3 Mapping diﬀerent candidate genes onto functional
networks
As indicated previously, the two population groups under consideration in
this study, namely the admixed SAC and the homogeneous Ghana-Gambia
have no disease associated gene in common. Nevertheless it is possible that
these genes interact and inﬂuence each other in the same sub-network to
produce similar eﬀect in these populations. Thus, examining the eﬀects of
these genes beyond single gene approach can shed light to the full
characterization of candidate genes and the genetic structure of TB in these
populations. In this section, we use human, MTB and human-MTB
protein-protein functional networks as an integrated system to check how
identiﬁed candidate genes work together in the same module or whether they
interact directly and indirectly with the pathogen.
We explored how candidate genes identiﬁed in diﬀerent populations interact
using the Protein Interaction Visualizer (PINV) tool (Salazar et al., 2014) at
http://biosual.cbio.uct.ac.za/pinViewer.html?core=HumanColl
(accessed on March 01 2016) by searching candidate genes for each
population as the protein queries. Figures 4.3 and 4.4 show the general
interaction structure of these proteins.
4.2.3.1 Graph-based relationships between candidate genes
Figure 4.3 shows the sub-network containing the SAC disease genes, which
potentially represents the SAC sub-network of interacting genes underlying
ethnic diﬀerences in disease risk. The disease gene Q725N4 has the biggest
degree of 899 interacting proteins and Q62VL6 has the smallest, 15 proteins.
Figure 4.4 shows a potential Ghana-Gambia sub-network of interacting
genes. From all A1KZ92 has the highest degree with 1087 interacting
partners. It is worth mentioning that one disease associated protein in the
homogeneous population, namely P32245 is a key protein, which is expected
to be evolutionary more conserved (Kaçar and Gaucher, 2013) than other
disease candidate proteins in the population. This happens because this gene
is likely to experience stronger selective constraints than other candidate
genes in the network due to its importance in the functioning of the
system (Albert et al., 2000).
Among 8 and 6 disease associated genes for the two populations, namely
Ghana-Gambia and SAC populations, respectively, 3 gene pairs interact in
common clusters: Q07020 and Q8NEX9, A1KZ92 and Q7Z5N4, and Q5T5C0
and A3KMH1. For the remaining genes in the set of candidate genes in the two
population groups each gene is singularly located in its cluster. The diﬀerence
in disease susceptibility between the two populations may come from these
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Figure 4.3: SAC disease genes mapped on to the human functional
network: The sub-network containing all identiﬁed SAC disease genes in
green and showing how these genes are connected.
disease associated proteins. Clusters containing disease genes are statistically
enriched with 1039 main biological processes and some of them are shown in
Table 4.6. Several processes are related to immune system and indicate that
these candidate genes may contribute to down-regulate various biological pro-
cesses, such as tissue repair and immune responses, among many others, and
may have an eﬀect in progression for infection to disease. This provides an
indication that these sub-networks are potentially associated with disease risk
in the population under consideration.
4.2.3.2 Prediction of human-MTB interactions inﬂuencing
susceptibility to tuberculosis
The infection outcome depends on the interplay between the timing and
concentration of various signalling molecules and this is critical for the fate of
the host-pathogen interaction. As consequence, the failure of this process
may yield increased susceptibility to the pathogen, which possibly negotiates
its entry into host cell by activating processes to thwart host defence
mechanisms. In this section, we identify potential MTB proteins which
interact with candidate proteins, in which case, these candidates genes may
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Table 4.6: Some statistically enriched biological processes in which
non common clusters containing disease candidate genes are in-
volved. For each process identiﬁed level of the term in the GO DAG de-
scription, p-value and corrected p-value following Bonferroni multiple testing
correction are provided.
Term ID Level Process Name P-value Corrected P-value
GO:0061485 11 memory T cell prolifera-
tion
5.93764e-06 0.02774
GO:0001865 12 NK T cell diﬀerentiation 5.56822e-09 2.60147e-05
GO:0050798 11 activated T cell prolifera-
tion
1.58631e-06 0.00741
GO:0045065 11 cytotoxic T cell diﬀerentia-
tion
1.65457e-08 7.73017e-05
GO:0043382 10 positive regulation of mem-
ory T cell diﬀerentiation
6.22663e-06 0.02909
GO:0072369 12 regulation of lipid trans-
port by positive regulation
of transcription from RNA
polymerase II promoter
9.09354e-11 4.24850e-07
GO:0034389 4 lipid particle organization 6.21640e-11 2.90430e-07
GO:1903955 10 positive regulation of pro-
tein targeting to mitochon-
drion, saturated fatty acid
2.73654e-07 0.00128
GO:0002291 11 T cell activation via T
cell receptor contact with
antigen bound to MHC
molecule on antigen pre-
senting cell
1.34764e-08 6.29621e-05
GO:0046597 8 negative regulation of viral
entry into host cell
3.57554e-08 0.00017
GO:0046007 10 negative regulation of acti-
vated T cell proliferation
8.38265e-06 0.03916
GO:0042492 11 gamma-delta T cell diﬀer-
entiation
4.27773e-08 0.00019
GO:0038168 11 epidermal growth factor re-
ceptor signaling pathway
via I-kappaB kinase/NF-
kappaB cascade
8.91922e-11 4.16706e-07
GO:0035457 6 cellular response to
interferon-alpha
3.12971e-07 0.00146
GO:0032608 5 interferon-beta production 1.33742e-09 6.24844e-06
GO:0034116 7 positive regulation of het-
erotypic cell-cell adhesion
3.18167e-07 0.00148
GO:1900165 10 negative regulation of
interleukin-6 secretion
1.11220e-08 5.19620e-05
GO:0050718 11 positive regulation of
interleukin-1 beta secre-
tion
2.30484e-07 0.00107
GO:0035963 6 cellular response to
interleukin-13
2.73974e-07 0.00128
GO:0032618 4 interleukin-15 production 3.28122e-08 0.00015
GO:0032632 5 interleukin-3 production 3.28122e-08 0.00015
GO:0071351 6 cellular response to
interleukin-18
2.73974e-07 0.00128
GO:2000778 10 positive regulation of
interleukin-6 secretion
3.89489e-11 1.81969e-07
GO:0045416 8 positive regulation of
interleukin-8 biosynthetic
process
1.03925e-05 0.04855
GO:0036016 6 cellular response to
interleukin-3
1.08243e-07 0.00050
GO:0071104 5 response to interleukin-9 5.93932e-07 0.00277
GO:0071105 5 response to interleukin-11 1.21508e-06 0.00567
GO:0030890 9 positive regulation of B cell
proliferation
8.30169e-12 3.87855e-08
GO:0002326 11 B cell lineage commitment 3.85891e-12 1.80288e-08
GO:0002331 13 pre-B cell allelic exclusion 7.36557e-11 3.44119e-07
GO:0001922 8 B-1 B cell homeostasis 7.49510e-08 0.00035
GO:0002337 13 B-1a B cell diﬀerentiation 6.81722e-11 3.18500e-07
GO:0002352 12 B cell negative selection 4.66575e-11 2.17984e-07
GO:0002358 8 B cell homeostatic prolifer-
ation
0.0 0.0
GO:0090340 9 positive regulation of secre-
tion of lysosomal enzymes
3.08500e-10 1.44131e-06
GO:0045429 8 positive regulation of nitric
oxide biosynthetic process
8.62045990146e-11 4.02747886596e-07
GO:0051000 8 positive regulation of
nitric-oxide synthase
activity
6.78463784265e-07 0.00316978280009
GO:0051001 8 negative regulation of
nitric-oxide synthase
activity
1.03924840439e-05 0.048553685453
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Figure 4.4: Ghana-Gambia disease genes mapped on to the network:
The sub-network containing all Ghana-Gambia signiﬁcant disease genes in
green and showing how these genes are connected.
potentially contribute to the various stages of the pathogen life cycle within
the host. These candidate genes may possibly help the pathogen to achieve
its goal, preventing host protective immunity against the pathogen and likely
to cause disease.
In the human-MTB functional network, the total number of human proteins
interacting with MTB is 255 and that of MTB proteins interacting with
human is 103.
From the list of candidate disease genes, the SAC disease associated genes
A3KMH1, Q9NQ90, and Q8NEX9 and their direct neighbours interact with
the pathogen. On another side, there are 349 MTB proteins interacting with
SAC disease genes or their direct interacting neighbours. Table 4.7 shows
statistically signiﬁcant or enriched biological processes in which these MTB
proteins are involved. For homogeneous group, the homogeneous disease
Table 4.7: Some statistically enriched biological processes in which
MTB proteins interacting with SAC disease genes or its partners
are involved. For each process identiﬁed level of the term in the GO DAG
description, p-value and corrected p-value following Bonferroni multiple testing
correction are provided.
Term ID Level Process Name P-value Corrected P-value
GO:0019367 11 fatty acid elongation 1.45863e-10 1.38570e-08
GO:0019605 10 butyrate metabolic pro-
cess
1.15010e-08 1.09260e-06
GO:0097089 9 methyl-branched fatty
acid metabolic process
1.15010e-08 1.09260e-06
GO:0001676 9 long-chain fatty acid
metabolic process
7.38368e-09 7.01449e-07
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associated genes with their direct neighbours interacting with the MTB
proteins are P32245, Q86Y38, A1KZ92, Q07020, Q5T5C0, Q8TEW8, and
O60669. On the other hand, the number of MTB proteins interacting with
homogeneous disease genes or its interacting partner is 18. In this case, we
searched for processes of clusters in which the proteins belong. These 18
interacting MTB proteins belong to six clusters involved in main signiﬁcant
biological processes shown in Table 4.8.
Table 4.8: Some statistically enriched biological processes in which
MTB proteins interacting with homogeneous disease genes or its
partners are involved. For each process identiﬁed level of the term in the GO
DAG description, p-value and corrected p-value following Bonferroni multiple
testing correction are provided.
Term ID Level Process Name P-value Corrected P-value
GO:0070929 9 trans-translation 2.61956e-11 9.32563e-09
GO:0006415 8 translational termina-
tion
4.61710e-11 1.64368e-08
GO:0001676 9 long-chain fatty acid
metabolic process
1.15763e-05 0.00412
GO:0006413 8 translational initiation 4.61710e-11 1.64368e-08
GO:0019605 10 butyrate metabolic pro-
cess
2.44826e-05 0.00871
GO:0019679 11 propionate metabolic
process, methylcitrate
cycle
1.48611e-05 0.00529
GO:0097089 9 methyl-branched fatty
acid metabolic process
2.44826e-05 0.00871
GO:0019367 11 fatty acid elongation,
saturated fatty acid
6.63498e-05 0.02362
The results obtained indicate that MTB proteins interacting with disease as-
sociated genes are involved in fatty acid related processes. Indeed, the number
of MTB proteins which are involved in the fatty acid related processes and
interact with disease associated genes in the two population groups, SAC and
homogeneous Ghana-Gambia, was more than expected by chance with p-values
6.72517e-12 and 5.85126e-05 respectively. Fatty acids are very important nutri-
ents for the survival of the MTB cells in the host environment (Kinsella et al.,
2003). MTB has approximately 250 genes involved in fatty acid metabolism,
a much higher proportion than in any other organism. Biosynthesis of fatty
acids is important because its mycolic acids, produced from elongated fatty
acids, plays an essential role in the formation of complex lipids layer on the
cell membrane which help it to survive inside the host, contributing to its vir-
ulence and pathogenesis. This membrane layer have been targeted by many
of the drugs used to treat MTB infection (Kinsella et al., 2003). MTB uses
the envelop of complex lipids on its cell membrane to protect itself in the host
environment.
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4.2.4 Retrieving potential enriched processes and
pathways of candidate genes
As pointed out previously, proteins can also interact with one another in
diﬀerent pathways and processes, which are responsible for the biological
dynamics of a system (Mulder et al., 2014), in which case, these proteins
inﬂuence each other either through enhancement or through hindrance. This
indicates that risk-associated genes may be diﬀerent between populations or
individuals, but may inﬂuence each other in the same pathway or contribute
to the same process. Thus, identifying and understanding pathways or
processes in which candidate genes are involved can provide a deeper insight
into the underlying genetic mechanisms of TB pathogenesis and may
contribute to the development of TB therapeutics. Here, we identiﬁed
statistically signiﬁcant processes and pathways in which candidate genes in
diﬀerent populations under consideration are involved.
Reading human-GO annotations to retrieve biological process terms
associated with the disease associated genes, the total number of biological
processes that involve the disease associated proteins in SAC population is 61
with 44 ﬁltered processes. Among these, 7 processes are found to be
statistically signiﬁcant. Table 4.9 presents the 7 signiﬁcant biological
processes in which the SAC disease associated proteins are involved. For the
Ghana-Gambia homogeneous population, 46 processes were identiﬁed with 35
ﬁltered processes, no enriched process was detected for the Ghana-Gambia
homogeneous population.
Table 4.9: Some statistically enriched biological processes in which
SAC disease associated proteins are involved. For each process identiﬁed
level of the term in the GO DAG description, p-value and corrected p-value
following Bonferroni multiple testing correction are provided.
Term ID Level Process Name P-value Corrected P-value
GO:0072284 11 metanephric S-shaped
body morphogenesis
0.00093 0.04116
GO:0035802 9 adrenal cortex formation 0.00047 0.02058
GO:2000195 6 negative regulation of fe-
male gonad development
0.00062 0.02744
GO:2001076 8 positive regulation of
metanephric ureteric bud
development
0.00031 0.01372
GO:0072302 11 negative regulation of
metanephric glomerular
mesangial cell prolifera-
tion
0.00016 0.00686
GO:0072166 11 posterior mesonephric
tubule development
0.00078 0.03430
GO:0060923 10 cardiac muscle cell fate
commitment
0.00093 0.04116
We performed a pathway enrichment analysis using set of human pathways
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collected from the KEGG pathway (Kanehisa and Goto, 2000). No enriched
pathway was identiﬁed for the SAC population and for the Ghana-Gambia
population, 2 enriched pathways were detected: Glycosaminoglycan
biosynthesis-chondroitin sulfate/dermatan sulfate (KEGG ID:hsa00532) and
Glycosaminoglycan biosynthesis-heparan sulfate/heparin (KEGG
ID:hsa00534), with adjusted p-values of 0.000245. These pathways are shown
in Figures 4.5 and 4.6. These pathways are likely to be triggered to enhance
Figure 4.5: Glycosaminoglycan biosynthesis-chondroitin sul-
fate/dermatan sulfate (KEGG ID:hsa00532). The KEGG map as
retrieved from the KEGG website (http://www.genome.jp/kegg-bin/show_
pathway?hsa00532).
the ﬁrst line of contact between pathogen and host cell, which is essential to
a pathogen's invasive potential, and activate biological interactions
inﬂuencing many physiological and pathological processes, including
cell-to-cell communication, adhesion and the immune response (Kamhi et al.,
2013). These interactions, GAGs modulate various biological processes, such
as cell adhesion, proliferation and migration, tissue repair, coagulation, and
immune responses, among many others. Glycosaminoglycanpathogen
interactions aﬀect most, if not all, the key steps of microbial pathogenesis,
including host cell invasion, cellcell transmission and evasion of host defense
mechanisms (Aquino et al., 2010). These host glycosaminoglycan pathways
mediates the entry of pathogens into human cells, and it has been observed
that in Drosophila ﬂy, this pathway promote pathogen virulence and to
confer susceptibility to infection (Aquino et al., 2010). These observations
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Figure 4.6: Glycosaminoglycan biosynthesis-heparan sulfate/heparin
(KEGG ID:hsa00534). The KEGG map as retrieved from the KEGG web-
site (http://www.genome.jp/kegg-bin/show_pathway?hsa00534).
indicate that glycosaminoglycanpathogen interactions serve diverse
functions that aﬀect the pathogenesis of infectious diseases.
As pointed out previously, the two population groups, the admixed coloured
population and the homogeneous Ghana-Gambia population do not share dis-
ease associated genes, however, we examine how close are these candidate genes
at the functional level based on the GO biological process terms using the sim-
ilarity measure discussed in section 3.5. So, we compute functional similarity
scores between protein pairs using the GO-Universal metric (Mazandu and
Mulder, 2014b) and cluster these proteins using distance (dissimilarity) scores
derived from functional similarity scores. Figure 4.7 shows how close are these
genes using the hierarchical clustering map or dendrogram. For example the
two proteins SDR9C7 and PXDNL in ﬁgure 4.7 clustered together and the
distance between the two is approximately 0.35. so, the functional similarity
score between the two proteins is S(SDR9C7, PXDNL) = 0.65. The two
proteins are functionally most similar compared to the other proteins. Sim-
ilarly, the proteins ANO2 (from SAC) and SLC16A7 (from Ghana-Gambia)
are clustered with similarity score of 0.58 approximately, indicating that the-
ses proteins are more similar functionally to each other than they are similar
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Figure 4.7: Hierarchical clustering map of disease genes. Horizontal
axis shows the distance or dissimilarity score between a pair of proteins or
clusters in the set of disease associated proteins. The proteins in green are
those from the homogeneous Ghana-Gambia population and the red ones are
the disease genes of the admixed SAC population. The hierarchical clustering
map shows how similar or dissimilar are gene or protein pairs at functional
level and shows their functional cluster group.
to other proteins. But the distance d(Q62V L6, Q86Y 38) is approximately 0.9
and their functional similarity is approximately 0.1. Therefore the two proteins
are functionally very diﬀerent. From Figure 4.7 we generally have two main
clusters and we see that most of the disease genes are dissimilar from each
other and dispersed. This indicates that these proteins have variety of func-
tional purposes in the system. Even the proteins within the same population
are functionally dissimilar.
4.3 Disease candidate genes and drug targets
Front-line TB therapies last at least six months using the initial combination
of isoniazid, rifampin, pyrazinamide, and ethambutal (Mulder et al., 2013), a
control strategy implemented in response to the global TB epidemic, known as
Directly Observed Therapy, Short-course (DOTS). It is worth mentioning that
these anti-TB compounds were introduced between 1952 and 1963 (Mazandu
and Mulder, 2012b): isoniazid (1952), pyrazinamide (1954), cycloserine (1955),
ethambutol (1962), and rifampin (1963), indicating that TB is still being
treated with a decades-old drug regimen. Adverse drug reaction contributes
to non-compliance with this long duration of TB treatment, leading to the
development of resistance, the main failure in TB treatment. Furthermore,
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using drugs or chemical agents/antibiotics to treat an infectious disease has
selective action on infective or pathogenic organisms and also has adverse side
eﬀects in humans, in which case the drug used can be either ineﬀective or
even toxic. 59% of drugs causing adverse side eﬀects are metabolized by poly-
morphic enzymes(Huang et al., 2006), indicating that genetic component is
one of the critical factors that contribute to TB treatment outcomes. In this
section, we investigate potential role of genetic factors in TB therapy outcome
in relation to disease associated genes in admixed (SAC) and homogeneous
(Ghana-Gambia) populations. Certain genetic variants or SNPs are associ-
ated with signiﬁcant changes in drug eﬃcacy, drug disposition (Roden et al.,
2006; Eichelbaum et al., 2006; Ma and Lu, 2011) as they may directly impact
drug metabolizing enzymes, drug targets and drug receptors (Ramos et al.,
2012). Thus, we map SNPs to drug targets and drug targets to the uniﬁed
functional network in order to examine relationships between front-line drug
targets and disease associated genes and to predict the interaction between
human and bacterial pathogen potentially inﬂuencing drug responses.
4.3.1 GO-based functional relationship between drug
targets
We used GO processes to examine functional similarity between drug targets
using GO-universal metric based on enriched process terms in which these
targets are involved. Thus, we retrieved protein biological processes most
pertinent to each target set, the set of drug target proteins. We obtained 53
ﬁltered processes associated with isoniazid drug target proteins and 12 are
signiﬁcant biological processes that are performed by isoniazid drug targets
as show in Table 4.10. There are 72 ﬁltered biological processes associated
with rifampin target proteins and 11 are signiﬁcant processes shown in
Table 4.11. There are 55 ﬁltered biological processes associated with
pyrazinamide target proteins and 16 are signiﬁcant processes performed by
pyrazinamide drug targets (see Table 4.12). There are no processes found
which are associated with ethambutol drug target, which has only one
putative targets, namely P11473, extracted from the Guide to Pharmacology
database. These target sets share some proteins in common and contribute
in several common biological processes, including exogenous drug catabolic
process (GO:0042738) and toxin biosynthetic process (GO:0009403).
We plot the hierarchical clustering map for the set of drug target proteins
that shows their pairwise functional similarity scores, assessing how close are
these targets to each other. The clustering results are shown in ﬁgure 4.8.
The vertical axis is the set of drug target proteins and the horizontal axis
represents the distance or dissimilarity between a pair of proteins or clusters.
In Figure 4.8 the target proteins in isoniazid are in red, proteins in rifampin
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Table 4.10: Some statistically enriched biological processes in which
isoniazid drug target proteins are involved. For each process identiﬁed
level of the term in the GO DAG description, p-value and corrected p-value
following Bonferroni multiple testing correction are provided.
Term ID Term Level Process Name P-value Corrected P-value
GO:0019373 11 epoxygenase P450 path-
way
3.01841e-11 1.53938e-09
GO:0006805 5 xenobiotic metabolic pro-
cess
0.0 0.0
GO:0006706 5 steroid catabolic process 1.97002e-05 0.00100
GO:0016098 7 monoterpenoid
metabolic process
0.0 0.0
GO:0097267 11 omega-hydroxylase P450
pathway
7.45685e-11 3.80299e-09
GO:0070989 4 oxidative demethylation 0.0 0.0
GO:0071615 4 oxidative deethylation 5.76946e-10 0.04116
GO:0090350 7 negative regulation of
cellular organoﬂuorine
metabolic process
0.00026 0.01325
GO:0009822 5 alkaloid catabolic process 1.82343e-07 9.29954e-06
GO:0046226 6 coumarin catabolic pro-
cess
0.00052 0.02651
GO:0009403 5 toxin biosynthetic pro-
cess
0.00026 0.01326
GO:0042738 5 exogenous drug catabolic
process
3.87484e-11 1.97617e-09
Table 4.11: Some statistically enriched biological processes in which
rifampin drug target proteins are involved. For each process identiﬁed
level of the term in the GO DAG description, p-value and corrected p-value
following Bonferroni multiple testing correction are provided.
Term ID Term Level Process Name P-value Corrected P-value
GO:0019373 11 epoxygenase P450 path-
way
0.0 0.0
GO:0006706 5 steroid catabolic process 4.58716e-05 0.00330
GO:0070980 7 biphenyl catabolic pro-
cess
0.00039 0.02807
GO:0016098 7 monoterpenoid
metabolic process
7.92217e-11 5.70396e-09
GO:0097267 11 omega-hydroxylase P450
pathway
4.69371e-11 3.37947e-09
GO:0070989 4 oxidative demethylation 0.0 0.0
GO:0071615 4 oxidative deethylation 2.50821e-11 1.80591e-09
GO:0006789 7 bilirubin conjugation 0.00039 0.02807
GO:0009822 5 alkaloid catabolic process 4.25558e-07 3.06401e-05
GO:0009403 5 toxin biosynthetic pro-
cess
0.00038 0.02807
GO:0042738 5 exogenous drug catabolic
process
0.0 0.0
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Table 4.12: Some statistically enriched biological processes in which
pyrazinamide drug target proteins are involved. For each process iden-
tiﬁed level of the term in the GO DAG description, p-value and corrected
p-value following Bonferroni multiple testing correction are provided.
Term ID Term Level Process Name P-value Corrected P-value
GO:2001213 8 negative regulation of vas-
culogenesis
0.00013 0.00714
GO:0042816 6 vitamin B6 metabolic pro-
cess
0.00065 0.03573
GO:0009822 5 alkaloid catabolic process 0.00039 0.02144
GO:0006805 5 xenobiotic metabolic pro-
cess
0.00033 0.01819
GO:1900747 7 negative regulation of vas-
cular endothelial growth
factor signaling pathway
0.00052 0.02859
GO:0036378 8 calcitriol biosynthetic pro-
cess from calciol
0.00052 0.02859
GO:0016098 7 monoterpenoid metabolic
process
0.00025 0.01392
GO:0060058 10 positive regulation of apop-
totic process involved in
mammary gland involution
0.00052 0.02859
GO:0070989 4 oxidative demethylation 1.41804e-06 7.79922e-05
GO:0045602 7 negative regulation of en-
dothelial cell diﬀerentia-
tion
0.00078 0.04288
GO:0006706 5 steroid catabolic process 4.38698e-06 0.00024
GO:0071615 4 oxidative deethylation 1.76591e-05 0.00097
GO:0009115 9 xanthine catabolic process 0.00026 0.01429
GO:0007595 8 lactation 1.21781e-05 0.00067
GO:0009403 5 toxin biosynthetic process 0.00013 0.00714
GO:0042738 5 exogenous drug catabolic
process
1.33501e-05 0.00073
Figure 4.8: Hierarchical clustering map for drug target proteins. Hor-
izontal axis shows the distance or dissimilarity score between a pair of proteins
or clusters in the set of drug target proteins. The target proteins in isoniazid
are in red, proteins in rifampin are in blue, proteins in pyrazinamide are in
black, and proteins in ethambutol are in green. But notice that the drugs have
common protein targets and those common targets take only one of the colors.
Stellenbosch University  https://scholar.sun.ac.za
CHAPTER 4. RESULTS AND DISCUSSION 52
are in blue, proteins in pyrazinamide are in black, and proteins in ethambutol
are in green. But notice that the drugs have common protein targets and
those common targets take only one of the colors. The protein P11473(VDR)
is common target for all the four drugs though it appears black in the
dendrogram. Similarly, P05177 (CYP1A2) and P08684(CYP3A4) are
common targets for the three drugs isoniazid, rifampin, and pyrazinamide.
P05181 (CYP2E1), P11712 (CYP2C9), P11509 (CYP2A6), P10632
(CYP2C8) are common targets for isoniazid and rifampin.
From Figure 4.8, we observe that rifampin protein targets
Q9HB55 and P24462 are the same functionally since the distance
d(Q9HB55, P24462) = 0. These two proteins and isoniazid target
protein P11245 are in the same cluster with dissimilarity score
d(P11245, P24462) = d(P11245, Q9HB55) ≈ 0.05. These proteins are the
most similar compared to the other proteins. The second most similar
proteins are P33261 and P20813 which are rifampin target proteins. The
common target protein for all drugs, P11473 (VDR) is in the same cluster
(similar) with the protein O75469 (NR1I2) of rifampin with similarity score
of approximately 0.55 and it is in the same cluster with the other proteins
with similarity score of 0.20.
In most cases, functional similarity values are greater than 0.5 and 15 out of
19 proteins belong to the same cluster. All protein targets of rifampin and
isoniazid except P22309 are in this big cluster and P05177 is the only target of
pyrazinamide which is also target for isoniazid and rifampin is in this cluster.
In general, using drug combination therapies is often necessary to ensure that
the disease is contained (Winter et al., 2012), but interactions between these
drugs can produce either antagonistic, indiﬀerent or synergistic eﬀects (Maity
et al., 2014). In the context of the TB front-line therapy, the fact that drug
targets share high functional similarity scores provides an indication that in-
teractions between these drugs are likely to produce synergistic or indiﬀerent
eﬀects. Thus, further pharmaco-kinetic or dynamic analysis of potential drug-
drug interactions are essential to determine drug response eﬀects.
4.3.2 Drug targets vs disease risk genes and MTB
system
In Table 4.13, we have TB front-line drugs protein targets with the number
of associated SNPs and closest distance SNPs (d = 0). These SNPs can be
responsible for drug metabolism and drug response. They are mostly found
in drug metabolising enzymes and they are responsible for variation in drug
response (Alwi, 2005). The front line target proteins or the pharmacogenes
we have considered are important in drug metabolism to have eﬀective
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output from the drug taken. From the result in Table 4.13 none of the drug
targets is found to be key proteins in the human functional network.
Interestingly, these drug targets share common clusters with disease
associated genes especially in the case of homogeneous population.
Regarding interaction with MTB proteins, only pyrazinamide target proteins
Q06278 and P47989 interact with MTB proteins. This provides an indication
that these targets are likely to treat the underlying cause of disease, but
further analyses are still needed to examine the eﬀectiveness of these targets.
Considering MTB proteins front-line drug targets; rifampin: P9WGY8,
isoniazid: P9WGR0, pyrazinamide: Q7D6Z3, and ethambutol: P9WNL4,
P9WNL8, P9WNL6. These target proteins are key proteins in MTB network
and they interact with human proteins except isoniazid target protein
P9WGR0. This may cause harmful side-eﬀects and contributes to drug
ineﬃciency (Mulder et al., 2013).
Table 4.13: Relationship between TB front-line drug targets and dis-
ease associated genes. Mapping diﬀerent SNPs to their corresponding hu-
man targets elucidating targets which are key proteins in the functional net-
works and identifying those interacting with the other organism proteins and
those located in the same cluster with disease associated genes. `1' indicates
that a target under consideration is a key protein/shared a common clusters
with disease associated genes/ interacts with the other organism (human or
pathogen), and `0' indicates otherwise.
Target ID Organism Key protein Interacting
with
MTB/Human
protein
Total Number
of SNPs
Closest SNP common
cluster as ad-
mixed disease
genes
common
cluster as
Homogeneous
disease genes
P11712 human 0 0 107 90 0 1
P05177 human 0 0 101 91 0 1
P10632 human 0 0 120 90 0 1
P08684 human 0 0 54 48 0 1
P20813 human 0 0 69 46 0 1
P22309 human 0 0 31 31 0 1
P33261 human 0 0 109 70 0 1
P11509 human 0 0 24 11 0 1
P05181 human 0 0 88 33 0 1
Q9HB55 human 0 0 38 30 1 1
P20815 human 0 0 42 31 0 1
P24462 human 0 0 49 39 0 1
Q02928 human 0 0 46 27 1 1
O75469 human 0 0 85 74 0 1
P11473 human 0 0 94 65 0 1
P10635 human 0 0 25 9 0 1
P11245 human 0 0 0 0 0 1
P47989 human 0 1 148 92 0 1
Q06278 human 0 1 170 109 1 1
P9WGY8 MTB 1 1 - -  -
P9WGR0 MTB 0 0 - -  -
Q7D6Z3 MTB 1 1 - -  -
P9WNL4 MTB 1 0 - -  -
P9WNL8 MTB 1 0 - -  -
P9WNL6 MTB 1 0 - -  -
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Conclusion
Currently, tuberculosis (TB) is a major global health challenge especially in
Sub-Saharan Africa. Signiﬁcant progress is being made to stop TB, but the
emergence of drug resistance MTB strains and its synergy with HIV make
the implementation of control measurement diﬃcult. TB latently infected
approximately one third of the world population and the admixed South
African Coloured (SAC) population which is located on the western cape of
South Africa has a high incidence of TB and is ideally suited to the discovery
of TB susceptibility genetic variants and their probable ethnic origins. In this
project, we used an integrated framework model to analyse susceptibility to
tuberculosis in homogeneous and admixed population. we analysed human
genetic susceptibility in relation to the MTB system. We identiﬁed potential
genes, biological processes, and pathways involved in TB susceptibility, and
the ancestry showing association with TB susceptibility in the admixed SAC
population. Furthermore, we have examined the relationship between
diﬀerent disease associated genes and front-line drug targets.
Using a graph-based model on human and MTB protein-protein functional
interactions, we have analyzed topological properties of the networks,
including small-world and scale-free properties of networks and characterized
key proteins in the network using centrality measures. Combining association
signals of GWAS and integrating with the human protein-protein functional
interaction network, we identiﬁed 6 disease associated genes for the admixed
SAC population and 8 disease associated genes for the homogeneous
Ghana-Gambia population. We identiﬁed clusters or sub-graphs in the
network containing these disease associated genes. We elucidated a total of 9
disease associated clusters where 3 of the clusters are common that contain
disease genes from both population groups and 6 clusters are non-common.
These genes can be responsible for the diﬀerence in genetic susceptibility to
TB between the two population groups.
Gene Ontology (GO) term and pathway enrichment analyses were performed
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targeting disease genes and their clusters, and TB ﬁrst line drug targets to elu-
cidate potential biological processes in which these genes contribute. Moreover,
for the admixed SAC population, we combined local ancestry contribution of
SNPs at gene level for the identiﬁed disease associated genes. We observed
that the African Khomani San ancestry of the SAC population is overrepre-
sented in all the disease genes, thus contributing to TB risk in this population
and this observation agrees with previous ﬁndings. A disease is often a result
of several interactions between proteins or genes aﬀecting multiple biological
processes and pathways. This suggest that the identiﬁcation of disease associ-
ated genes and their underling biological processes and pathways can advance
our understanding of TB pathogenesis and may be useful for the development
of novel drugs based on target proteins and processes involved in the disease.
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